Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	1431060	1431060	T	C	exonic	ATAD3B	.	nonsynonymous SNV	ATAD3B:NM_001317238:exon14:c.T1672C:p.Y558H,ATAD3B:NM_031921:exon16:c.T1810C:p.Y604H	1.92E-13	0.056353554	0.943646446	.	0.08529	0.12376	2.166192036	98.0301958	6153.92777	16.40046	0.602	0.056	T	0.0	0.026	B	0.0	0.013	B	0.371	0.044	U	1	0.090	N	-0.69	0.019	N	-3.43	0.944	D	-0.05	0.078	N	0.072	0.097	-0.401	0.720	T	0.539	0.830	D	.	.	.	-1.923	0.009	0.001	0.220	0.009	0.006	0.026	N	c	-1.783	-1.863	0.002	0.089	0.707	0.730	0	-2.41	0.061	-1.313	0.028	-1.859	0.006	0.000	0.063	0.000	0.016	2.734	0.049	.	.	.	0.5	125	243	chr1	1431060	chr1:1431060	T	C	125	PASS	AN=2;DP=243	GT	0/1
chr1	8424165	8424165	T	G	exonic	RERE	.	nonsynonymous SNV	RERE:NM_001042682:exon5:c.A29C:p.D10A,RERE:NM_001042681:exon15:c.A1691C:p.D564A,RERE:NM_012102:exon16:c.A1691C:p.D564A	0.999995655	4.34E-06	1.54E-16	DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; 	0.87038	0.13942	-2.629516077	0.784383109	607.52718	4.98583	0.009	0.682	D	0.999	0.764	D	0.994	0.807	D	.	.	.	1	0.810	D	1.15	0.294	L	3.46	0.053	T	-2.91	0.630	D	0.83	0.818	-0.908	0.471	T	0.027	0.114	T	0.029	0.513	D	4.919	0.661	25.0	0.981	0.381	0.993	0.938	D	c	0.451	0.509	1.000	0.747	0.719	0.830	0	5.17	0.707	7.448	0.795	1.061	0.807	1.000	0.715	1.000	0.888	14.340	0.660	.	.	.	0.5	176	123	chr1	8424165	chr1:8424165	T	G	176	PASS	AN=2;DP=123	GT	1/0
chr1	11254843	11254843	T	C	intronic	ANGPTL7;MTOR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	31	chr1	11254843	chr1:11254843	T	C	67	PASS	AN=2;DP=31	GT	0/1
chr1	17085791	17085791	G	A	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon8:c.C1030T:p.R344C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	424	chr1	17085791	chr1:17085791	G	A	.	PASS	AN=0;DP=424	GT	0/1
chr1	22030891	22030891	-	A	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	22	chr1	22030891	chr1:22030891	C	CA	55	PASS	AN=2;DP=22	GT	0/1
chr1	22332319	22332319	G	A	intronic	CELA3A	.	.	.	9.82E-08	0.312809271	0.68719063	.	0.69428	0.10766	-0.356299879	29.31115829	985.05923	6.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	177	chr1	22332319	chr1:22332319	G	A	77	PASS	AN=2;DP=177	GT	0/1
chr1	29189597	29189597	C	T	exonic	OPRD1	.	synonymous SNV	OPRD1:NM_000911:exon3:c.C921T:p.G307G	0.109062189	0.776662875	0.114274936	.	0.38858	0.34596	-0.139478553	43.29440906	296.04535	3.67407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	153	chr1	29189597	chr1:29189597	C	T	137	PASS	AN=2;DP=153	GT	0/1
chr1	46082112	46082112	T	G	intronic	NASP	.	.	.	0.4702163	0.529737965	4.57E-05	.	0.82873	0.14655	-0.176292081	40.56381222	111.92131	2.30362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	109	chr1	46082112	chr1:46082112	T	G	45	PASS	AN=2;DP=109	GT	0/1
chr1	47338888	47338888	C	A	ncRNA_intronic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	51	chr1	47338888	chr1:47338888	C	A	133	PASS	AN=2;DP=51	GT	1/0
chr1	62175139	62175139	-	T	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	59	chr1	62175139	chr1:62175139	A	AT	63	PASS	AN=2;DP=59	GT	0/1
chr1	84355735	84355748	AGAACTTCAAGGAT	-	intronic	TTLL7	.	.	.	0.268072469	0.731927454	7.64E-08	.	0.20746	0.09426	-0.754958418	13.57631517	77.26727	1.8459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	24	chr1	84355734	chr1:84355734	AAGAACTTCAAGGAT	A	106	PASS	AN=2;DP=24	GT	1/0
chr1	89449508	89449508	-	T	exonic	RBMXL1	.	frameshift insertion	RBMXL1:NM_019610:exon2:c.1dupA:p.M1Nfs*2,RBMXL1:NM_001162536:exon3:c.1dupA:p.M1Nfs*2	0.119596956	0.87492457	0.005478474	.	0.20063	.	0.72761005	86.08162302	80.60629	1.89749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	120	chr1	89449508	chr1:89449508	A	AT	69	PASS	AN=2;DP=120	GT	0/1
chr1	97981395	97981395	T	C	exonic	DPYD	.	nonsynonymous SNV	DPYD:NM_000110:exon13:c.A1627G:p.I543V	4.19E-09	0.996985954	0.003014042	.	0.29965	0.38628	1.431149089	95.02241095	1997.46528	8.23273	0.111	0.290	T	0.0	0.026	B	0.0	0.013	B	0.007	0.314	N	1.000	0.197	P	0.49	0.133	N	-0.8	0.739	T	0.73	0.021	N	0.023	0.006	-1.011	0.266	T	0.053	0.225	T	.	.	.	0.829	0.173	9.639	0.960	0.278	0.809	0.401	D	c	-1.000	-0.919	0.007	0.115	0.693	0.558	0	-3.13	0.049	1.397	0.339	-0.169	0.106	0.994	0.380	0.975	0.474	9.702	0.392	Aldolase-type TIM barrel|Dihydroorotate dehydrogenase domain	.	.	0.5	71	49	chr1	97981395	chr1:97981395	T	C	71	PASS	AN=2;DP=49	GT	0/1
chr1	114025434	114025434	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	226	chr1	114025434	chr1:114025434	C	CT	107	PASS	AN=2;DP=226	GT	0/1
chr1	121103633	121103633	-	T	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	218	chr1	121103631	chr1:121103631	CTT	CTTT,C	84	PASS	AN=2;DP=218	GT	0/1
chr1	121103632	121103633	TT	-	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	218	chr1	121103631	chr1:121103631	CTT	CTTT,C	84	PASS	AN=2;DP=218	GT	0/1
chr1	142819371	142819371	-	T	intergenic	ANKRD20A12P;LOC102723769	dist=105766;dist=315232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.52	106	chr1	142819371	chr1:142819371	G	GT	13.52	PASS	AN=0;DP=106	GT	0/1
chr1	143237559	143237559	C	T	intergenic	LOC102723769;MIR6077	dist=35320;dist=435362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	90	chr1	143237559	chr1:143237559	C	T	103	PASS	AN=2;DP=90	GT	0/1
chr1	144873811	144873811	A	G	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	124	chr1	144873811	chr1:144873811	A	G	91	PASS	AN=2;DP=124	GT	0/1
chr1	145014738	145014738	G	C	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	127	chr1	145014738	chr1:145014738	G	C	84	PASS	AN=2;DP=127	GT	0/1
chr1	151196702	151196702	-	T	intronic	PIP5K1A	.	.	.	0.014586299	0.985162174	0.000251527	.	0.12043	0.12792	-0.514264485	21.41424864	69.18119	1.72333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	150	chr1	151196702	chr1:151196702	G	GT	68	PASS	AN=2;DP=150	GT	0/1
chr1	153516163	153516163	A	-	UTR3	S100A4	NM_019554:c.*72delT;NM_002961:c.*72delT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	242	chr1	153516162	chr1:153516162	GA	G,GAA	80	PASS	AN=2;DP=242	GT	0/1
chr1	153516163	153516163	-	A	UTR3	S100A4	NM_019554:c.*71_*72insT;NM_002961:c.*71_*72insT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	242	chr1	153516162	chr1:153516162	GA	G,GAA	80	PASS	AN=2;DP=242	GT	0/1
chr1	154207835	154207835	T	-	intronic	UBAP2L	.	.	.	0.999999873	1.27E-07	3.41E-18	.	0.11769	0.11029	-1.109541557	6.782259967	61.03443	1.58905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	79	chr1	154207834	chr1:154207834	AT	A	89	PASS	AN=2;DP=79	GT	0/1
chr1	155307999	155307999	-	T	exonic	ASH1L	.	frameshift insertion	ASH1L:NM_018489:exon27:c.8683dupA:p.T2895Nfs*3	1	1.66E-13	1.32E-34	.	0.35554	.	-1.798985783	2.223401746	588.79734	4.92053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	396	chr1	155307999	chr1:155307999	G	GT	80	PASS	AN=2;DP=396	GT	0/1
chr1	161580116	161580116	G	T	intergenic	HSPA7;FCGR3B	dist=1775;dist=12872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	240	chr1	161580116	chr1:161580116	G	T	74	PASS	AN=2;DP=240	GT	0/1
chr1	168549282	168549282	-	T	intronic	XCL1	.	.	.	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	292	chr1	168549282	chr1:168549282	G	GT	81	PASS	AN=2;DP=292	GT	0/1
chr1	198677416	198677416	-	T	intronic	PTPRC	.	.	.	0.999941156	5.88E-05	3.61E-15	DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive (T(-)B()NK() SCID) [MIM:608971]: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. {ECO:0000269|PubMed:11145714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis (MS) [MIM:126200]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:11101853}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; 	0.17677	0.67006	0.231457213	68.57159707	71.3304	1.75714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	176	chr1	198677416	chr1:198677416	A	AT	67	PASS	AN=2;DP=176	GT	0/1
chr1	207888640	207888640	-	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	332	chr1	207888640	chr1:207888640	C	CT	94	PASS	AN=2;DP=332	GT	0/1
chr1	209880509	209880509	A	-	ncRNA_intronic	LOC101930114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	19	chr1	209880508	chr1:209880508	GA	G	80	PASS	AN=2;DP=19	GT	0/1
chr1	209936964	209936964	-	CA	intronic	TRAF3IP3	.	.	.	1.38E-06	0.989497509	0.010501115	.	0.25181	0.12101	0.286674996	71.49681529	267.89298	3.51107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	34	chr1	209936964	chr1:209936964	T	TCA	113	PASS	AN=2;DP=34	GT	1/0
chr1	223168205	223168205	-	T	intronic	DISP1	.	.	.	4.23E-06	0.997859918	0.002135849	.	0.16068	0.11183	0.369203982	74.77589054	4506.07665	13.48325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	151	chr1	223168205	chr1:223168205	C	CT	70	PASS	AN=2;DP=151	GT	0/1
chr1	236724605	236724605	G	T	intronic	HEATR1	.	.	.	0.999999993	6.78E-09	9.22E-25	.	0.09748	0.08985	2.322745612	98.36635999	19763.61088	30.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	81	chr1	236724605	chr1:236724605	G	T	141	PASS	AN=2;DP=81	GT	1/0
chr1	243594955	243594955	T	-	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	208	chr1	243594954	chr1:243594954	AT	A	64	PASS	AN=2;DP=208	GT	0/1
chr1	245017649	245017649	C	A	UTR3	HNRNPU	NM_004501:c.*103G>T;NM_031844:c.*103G>T	.	.	0.999903323	9.67E-05	7.22E-12	.	0.51398	0.38821	-0.60427181	17.74593064	41.32875	1.20799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	165	chr1	245017649	chr1:245017649	C	A	77	PASS	AN=2;DP=165	GT	0/1
chr2	10095020	10095020	-	T	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	173	chr2	10095020	chr2:10095020	G	GT	64	PASS	AN=2;DP=173	GT	0/1
chr2	36776617	36776617	T	-	UTR3	CRIM1	NM_016441:c.*773delT	.	.	0.977883079	0.022116914	6.98E-09	.	0.26394	.	-1.100469982	6.929700401	649.0811	5.11079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	95	chr2	36776616	chr2:36776616	CT	C	106	PASS	AN=2;DP=95	GT	0/1
chr2	39234343	39234343	A	-	intronic	SOS1	.	.	.	0.999999895	1.05E-07	1.77E-20	DISEASE: Noonan syndrome 4 (NS4) [MIM:610733]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS4 have polyarticular villonodular synovitis. {ECO:0000269|PubMed:17143282, ECO:0000269|PubMed:17143285, ECO:0000269|PubMed:19020799, ECO:0000269|PubMed:19438935, ECO:0000269|PubMed:19953625, ECO:0000269|PubMed:20673819, ECO:0000269|PubMed:20683980, ECO:0000269|PubMed:21387466}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72054	0.38414	-0.995664936	8.539749941	106.78667	2.24216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	184	chr2	39234342	chr2:39234342	TA	T	70	PASS	AN=2;DP=184	GT	0/1
chr2	42508204	42508204	-	A	intronic	EML4	.	.	.	0.391138665	0.608861306	2.84E-08	.	0.20914	0.1283	-1.346642726	4.62962963	2437.31101	9.17493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.32	49	chr2	42508204	chr2:42508204	C	CA	10.32	PASS	AN=0;DP=49	GT	0/1
chr2	42922888	42922888	-	T	intronic	MTA3	.	.	.	0.855163472	0.144816431	2.01E-05	.	0.83041	0.14229	-0.602450568	17.91106393	51.94859	1.42352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	60	chr2	42922888	chr2:42922888	A	AT	12.94	PASS	AN=0;DP=60	GT	0/1
chr2	43768233	43768233	-	A	intronic	THADA	.	.	.	1.24E-28	0.003148502	0.996851498	.	0.09919	0.09816	0.448132652	77.98419439	4895.75241	14.23268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	71	chr2	43768233	chr2:43768233	T	TA	51	PASS	AN=2;DP=71	GT	0/1
chr2	44445605	44445605	T	-	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	89	chr2	44445604	chr2:44445604	GT	G,GTT	86	PASS	AN=2;DP=89	GT	0/1
chr2	44445605	44445605	-	T	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	89	chr2	44445604	chr2:44445604	GT	G,GTT	86	PASS	AN=2;DP=89	GT	0/1
chr2	48941191	48941191	T	A	exonic	LHCGR	.	nonsynonymous SNV	LHCGR:NM_000233:exon7:c.A539T:p.K180I	2.80E-08	0.490421431	0.509578541	DISEASE: Luteinizing hormone resistance (LHR) [MIM:238320]: An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias. {ECO:0000269|PubMed:12050206, ECO:0000269|PubMed:15372531, ECO:0000269|PubMed:15472221, ECO:0000269|PubMed:19551906, ECO:0000269|PubMed:7719343, ECO:0000269|PubMed:8559204, ECO:0000269|PubMed:9215288, ECO:0000269|PubMed:9514160, ECO:0000269|PubMed:9626144, ECO:0000269|PubMed:9626653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13036	0.42555	0.356452144	74.62845011	1328.76039	6.85266	0.034	0.574	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	D	1.000	0.810	D	0.995	0.252	L	-1.57	0.819	D	-3.84	0.823	D	0.829	0.831	0.180	0.856	D	0.618	0.865	D	0.274	0.900	D	4.738	0.635	24.7	0.995	0.706	0.939	0.593	D	c	0.638	0.645	1.000	0.489	0.487	0.133	0	5.52	0.821	5.074	0.640	1.061	0.807	1.000	0.715	0.994	0.587	14.976	0.708	Leucine-rich repeat domain, L domain-like	.	.	0.5	103	103	chr2	48941191	chr2:48941191	T	A	103	PASS	AN=2;DP=103	GT	0/1
chr2	54756587	54756587	-	A	ncRNA_exonic	RPL23AP32	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	636	chr2	54756587	chr2:54756587	C	CA	83	PASS	AN=2;DP=636	GT	0/1
chr2	70463168	70463168	-	A	intronic	TIA1	.	.	.	0.832581092	0.167412892	6.02E-06	DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90768	0.26333	0.238945317	69.20853975	83.28929	1.94032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.64	57	chr2	70463168	chr2:70463168	T	TA	18.64	PASS	AN=0;DP=57	GT	0/1
chr2	91795525	91795525	G	T	intergenic	NONE;LOC654342	dist=NONE;dist=29184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	403	chr2	91795525	chr2:91795525	G	T	.	PASS	AN=0;DP=403	GT	0/1
chr2	96457946	96457946	T	C	intergenic	TRIM43;LINC00342	dist=192427;dist=14854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	162	117	chr2	96457946	chr2:96457946	T	C	162	PASS	AN=2;DP=117	GT	0/1
chr2	101640086	101640086	-	T	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	161	chr2	101640086	chr2:101640086	G	GT	77	PASS	AN=2;DP=161	GT	0/1
chr2	109404474	109404474	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	chr2	109404474	chr2:109404474	C	CT	87	PASS	AN=2;DP=131	GT	0/1
chr2	131984320	131984320	C	T	intronic	POTEE	.	.	.	.	.	.	.	.	.	.	.	513.98926	4.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	197	chr2	131984320	chr2:131984320	C	T	124	PASS	AN=2;DP=197	GT	0/1
chr2	139328964	139328964	-	T	UTR3	SPOPL	NM_001001664:c.*2314_*2315insT	.	.	0.045446953	0.953443578	0.00110947	.	0.32484	0.11621	-0.0274281	51.65723048	55.42268	1.49467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	139	chr2	139328964	chr2:139328964	A	AT	63	PASS	AN=2;DP=139	GT	0/1
chr2	157186619	157186619	G	T	exonic	NR4A2	.	stopgain	NR4A2:NM_006186:exon3:c.C80A:p.S27X	0.991432866	0.008565133	2.00E-06	.	0.64744	0.60715	-0.626318434	17.03231894	29.24717	0.93603	.	.	.	.	.	.	.	.	.	0.010	0.301	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.397	0.967	36	0.990	0.491	0.958	0.660	D	c	0.937	0.824	1.000	0.747	0.549	0.223	0	5.43	0.789	6.401	0.730	1.048	0.713	1.000	0.715	1.000	0.888	19.013	0.928	.	.	.	0.5	.	107	chr2	157186619	chr2:157186619	G	T	.	PASS	AN=0;DP=107	GT	0/1
chr2	158721458	158721458	-	T	intronic	ACVR1	.	.	.	0.956448193	0.043547277	4.53E-06	.	0.99535	0.38424	-0.514264485	21.41424864	58.72963	1.55397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.47	93	chr2	158721458	chr2:158721458	A	AT	10.47	PASS	AN=0;DP=93	GT	0/1
chr2	174829848	174829848	G	A	intronic	SP3	.	.	.	0.992297744	0.007701944	3.12E-07	.	0.96279	0.19114	-0.067881249	48.69072895	885.01092	5.79517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	2357	chr2	174829848	chr2:174829848	G	A	110	PASS	AN=2;DP=2357	GT	0/1
chr2	178092595	178092595	T	C	intergenic	HNRNPA3;NFE2L2	dist=3908;dist=2436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	302	chr2	178092595	chr2:178092595	T	C	83	PASS	AN=2;DP=302	GT	0/1
chr2	179321703	179321703	-	T	ncRNA_intronic	MIR548N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	351	chr2	179321703	chr2:179321703	A	AT	88	PASS	AN=2;DP=351	GT	0/1
chr2	182775402	182775402	-	T	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	194	chr2	182775402	chr2:182775402	G	GT	69	PASS	AN=2;DP=194	GT	0/1
chr2	183841692	183841692	A	-	intronic	NCKAP1	.	.	.	0.999999991	9.29E-09	5.84E-21	.	0.53149	0.18619	-1.199555187	5.761972163	23.37723	0.77966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	244	chr2	183841691	chr2:183841691	GA	G	124	PASS	AN=2;DP=244	GT	0/1
chr2	186629349	186629349	G	A	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	40	chr2	186629349	chr2:186629349	G	A	101	PASS	AN=2;DP=40	GT	0/1
chr2	189393929	189393929	-	T	intronic	GULP1	.	.	.	0.67755775	0.321474383	0.000967867	.	0.49297	0.14271	-0.229483771	36.86010852	19.84674	0.67647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	169	chr2	189393929	chr2:189393929	C	CT	63	PASS	AN=2;DP=169	GT	0/1
chr2	196891589	196891589	C	T	exonic	DNAH7	.	nonsynonymous SNV	DNAH7:NM_018897:exon7:c.G562A:p.V188I	1.04E-47	0.815068072	0.184931928	.	0.23862	0.10363	5.09315636	99.81717386	6415.17778	16.77483	1.0	0.096	T	0.027	0.182	B	0.019	0.176	B	0.000	0.523	D	1.000	0.513	D	1.035	0.257	L	2.2	0.186	T	-0.04	0.140	N	0.328	0.471	-1.074	0.085	T	0.038	0.165	T	0.004	0.088	T	1.570	0.250	13.69	0.997	0.773	0.789	0.387	D	c	-0.416	-0.236	1.000	0.415	0.487	0.133	0	5.92	0.955	1.692	0.371	0.935	0.490	0.951	0.329	0.208	0.219	19.912	0.970	.	.	.	0.5	78	139	chr2	196891589	chr2:196891589	C	T	78	PASS	AN=2;DP=139	GT	0/1
chr2	200136195	200136195	T	-	UTR3	SATB2	NM_001172509:c.*739delA;NM_001172517:c.*739delA;NM_015265:c.*739delA	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	87	chr2	200136194	chr2:200136194	CT	C,CTT	57	PASS	AN=2;DP=87	GT	0/1
chr2	200136195	200136195	-	T	UTR3	SATB2	NM_001172509:c.*738_*739insA;NM_001172517:c.*738_*739insA;NM_015265:c.*738_*739insA	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	87	chr2	200136194	chr2:200136194	CT	C,CTT	57	PASS	AN=2;DP=87	GT	0/1
chr2	201950166	201950166	-	T	intronic	NDUFB3	.	.	.	0.042565284	0.660300175	0.29713454	.	0.07174	.	0.21326276	67.71644256	9.41646	0.34679	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	27	chr2	201950166	chr2:201950166	C	CT	43	PASS	AN=2;DP=27	GT	0/1
chr2	202978199	202978199	T	-	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	328	chr2	202978198	chr2:202978198	GT	G	82	PASS	AN=2;DP=328	GT	0/1
chr2	217288388	217288388	G	C	exonic	SMARCAL1	.	nonsynonymous SNV	SMARCAL1:NM_001127207:exon6:c.G1129C:p.E377Q,SMARCAL1:NM_014140:exon6:c.G1129C:p.E377Q	0.000314359	0.999152781	0.000532861	DISEASE: Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]: Causes spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. Approximately half of all patients also exhibit hyperthyroidism, while around half also exhibit episodal cerebral ischemia. {ECO:0000269|PubMed:11799392}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06763	0.12074	-0.126743121	44.0905874	1034.25533	6.17659	0.068	0.446	T	0.425	0.336	B	0.324	0.401	B	0.000	0.559	D	0.000	0.511	P	2.56	0.750	M	-0.8	0.739	T	-1.09	0.283	N	0.108	0.397	-0.870	0.506	T	0.005	0.018	T	.	.	.	4.871	0.654	24.9	0.997	0.801	0.986	0.847	D	c	0.387	0.461	1.000	0.747	0.707	0.730	0	4.54	0.551	5.668	0.675	1.048	0.713	1.000	0.715	0.999	0.750	13.416	0.602	HARP domain	.	.	0.5	117	61	chr2	217288388	chr2:217288388	G	C	117	PASS	AN=2;DP=61	GT	0/1
chr2	220435104	220435104	C	T	exonic	OBSL1	.	nonsynonymous SNV	OBSL1:NM_001173408:exon1:c.G851A:p.R284H,OBSL1:NM_001173431:exon1:c.G851A:p.R284H,OBSL1:NM_015311:exon1:c.G851A:p.R284H	6.64E-16	0.777707244	0.222292756	.	0.18328	.	-0.814205844	12.01934418	4573.34304	13.56826	0.039	0.424	D	0.994	0.899	D	0.931	0.679	D	.	.	.	1	0.810	D	1.47	0.371	L	-0.63	0.720	T	-1.54	0.381	N	0.131	0.199	-0.603	0.647	T	0.264	0.635	T	0.264	0.897	D	3.453	0.473	23.0	0.999	0.960	0.053	0.111	N	c	-0.032	-0.137	1.000	0.517	0.455	0.088	0	1.41	0.214	0.003	0.129	0.036	0.152	0.000	0.063	0.976	0.476	7.173	0.247	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	85	chr2	220435104	chr2:220435104	C	T	.	PASS	AN=0;DP=85	GT	0/1
chr2	228109625	228109625	-	TG	ncRNA_intronic	LOC654841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	182	chr2	228109625	chr2:228109625	T	TTG	90	PASS	AN=2;DP=182	GT	0/1
chr2	235403512	235403512	A	-	UTR3	ARL4C	NM_001282431:c.*938delT;NM_005737:c.*1140delT	.	.	0.607389355	0.356926815	0.03568383	.	0.6781	0.1291	0.035072054	56.2514744	1.39352	0.04935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	88	chr2	235403511	chr2:235403511	TA	T,TAA	86	PASS	AN=2;DP=88	GT	0/1
chr2	235403512	235403512	-	A	UTR3	ARL4C	NM_001282431:c.*937_*938insT;NM_005737:c.*1139_*1140insT	.	.	0.607389355	0.356926815	0.03568383	.	0.6781	0.1291	0.035072054	56.2514744	1.39352	0.04935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	88	chr2	235403511	chr2:235403511	TA	T,TAA	86	PASS	AN=2;DP=88	GT	0/1
chr2	241808307	241808307	-	C	exonic	AGXT	.	frameshift insertion	AGXT:NM_000030:exon1:c.26dupC:p.K12Qfs*155	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	761	chr2	241808307	chr2:241808307	A	AC	97	PASS	AN=2;DP=761	GT	0/1
chr3	9408575	9408575	-	T	intronic	THUMPD3	.	.	.	4.00E-11	0.093421697	0.906578303	.	0.13906	0.09925	0.266447942	70.5826846	866.34515	5.73321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	36	chr3	9408575	chr3:9408575	C	CT	43	PASS	AN=2;DP=36	GT	0/1
chr3	24270412	24270412	-	A	intronic	THRB	.	.	.	0.994541861	0.005457474	6.65E-07	DISEASE: Generalized thyroid hormone resistance (GTHR) [MIM:188570]: A disease characterized by goiter, abnormal mental functions, increased susceptibility to infections, abnormal growth and bone maturation, tachycardia and deafness. Affected individuals may also have attention deficit-hyperactivity disorders (ADHD) and language difficulties. GTHR patients also have high levels of circulating thyroid hormones (T3-T4), with normal or slightly elevated thyroid stimulating hormone (TSH). {ECO:0000269|PubMed:10660344, ECO:0000269|PubMed:1314846, ECO:0000269|PubMed:1324420, ECO:0000269|PubMed:1563081, ECO:0000269|PubMed:1587388, ECO:0000269|PubMed:1619012, ECO:0000269|PubMed:1661299, ECO:0000269|PubMed:16804041, ECO:0000269|PubMed:1846005, ECO:0000269|PubMed:19268523, ECO:0000269|PubMed:2153155, ECO:0000269|PubMed:2510172, ECO:0000269|PubMed:7833659, ECO:0000269|PubMed:8175986, ECO:0000269|PubMed:8514853, ECO:0000269|PubMed:8664910, ECO:0000269|PubMed:8889584}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Generalized thyroid hormone resistance autosomal recessive (GTHRAR) [MIM:274300]: An autosomal recessive disorder characterized by goiter, clinical euthyroidism, end-organ unresponsiveness to thyroid hormone, abnormal growth and bone maturation, and deafness. Patients also have high levels of circulating thyroid hormones, with elevated thyroid stimulating hormone. {ECO:0000269|PubMed:1653889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650]: Variant form of thyroid hormone resistance and is characterized by clinical hyperthyroidism, with elevated free thyroid hormones, but inappropriately normal serum TSH. Unlike GRTH, where the syndrome usually segregates with a dominant allele, the mode of inheritance in PRTH has not been established. {ECO:0000269|PubMed:7528740, ECO:0000269|PubMed:8381821}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87928	0.51098	-0.471992905	23.03609342	18.48609	0.63978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	55	chr3	24270412	chr3:24270412	T	TA	76	PASS	AN=2;DP=55	GT	0/1
chr3	38137959	38137959	-	T	intronic	DLEC1	.	.	.	6.45E-18	0.99562723	0.00437277	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription may be implicated in the development of esophageal cancer.; 	0.98238	0.10873	0.161491526	64.92686954	3130.50362	10.64467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	168	chr3	38137959	chr3:38137959	G	GT	80	PASS	AN=2;DP=168	GT	0/1
chr3	40550121	40550121	-	T	intronic	ZNF620	.	.	.	6.83E-06	0.715071728	0.284921445	.	0.10981	.	0.350995466	74.37485256	198.29097	3.04284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.08	45	chr3	40550121	chr3:40550121	C	CT	10.08	PASS	AN=0;DP=45	GT	0/1
chr3	47263926	47263926	T	-	ncRNA_intronic	KIF9-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	53	chr3	47263925	chr3:47263925	CT	C	97	PASS	AN=2;DP=53	GT	0/1
chr3	48226193	48226193	-	A	intronic	CDC25A	.	.	.	0.979698045	0.020301273	6.82E-07	.	0.99898	0.37326	-0.291981272	33.20358575	96.05413	2.11781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.14	41	chr3	48226193	chr3:48226193	G	GA	11.14	PASS	AN=0;DP=41	GT	0/1
chr3	55543261	55543261	-	T	UTR3	ERC2	NM_015576:c.*2082_*2083insA	.	.	0.996856462	0.003143537	5.86E-11	.	0.79983	0.1105	-0.328796968	30.86223166	667.89389	5.16807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	34	chr3	55543261	chr3:55543261	G	GT	67	PASS	AN=2;DP=34	GT	0/1
chr3	57843748	57843748	-	T	intronic	SLMAP	.	.	.	0.999325965	0.000674035	6.78E-12	.	0.43101	0.11509	-1.155457828	6.168907761	40.3211	1.1843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	30	chr3	57843748	chr3:57843748	C	CT	83	PASS	AN=2;DP=30	GT	0/1
chr3	122811188	122811188	-	T	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	AN=2;DP=246	GT	0/1
chr3	122811188	122811188	T	-	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	AN=2;DP=246	GT	0/1
chr3	122811188	122811188	-	TTT	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	chr3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	AN=2;DP=246	GT	0/1
chr3	129207068	129207070	TCT	-	intronic	IFT122	.	.	.	2.16E-11	0.999599617	0.000400383	.	0.37127	0.14087	-1.271459448	5.207596131	277.35114	3.56725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	52	chr3	129207067	chr3:129207067	GTCT	G	119	PASS	AN=2;DP=52	GT	0/1
chr3	132363753	132363753	A	-	ncRNA_intronic	NPHP3-ACAD11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	135	chr3	132363752	chr3:132363752	TA	T	85	PASS	AN=2;DP=135	GT	0/1
chr3	141696554	141696554	-	T	intronic	TFDP2	.	.	.	0.975087598	0.024911272	1.13E-06	.	0.96272	0.18236	-0.139478553	43.29440906	42.91096	1.24214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	270	chr3	141696554	chr3:141696554	A	AT	77	PASS	AN=2;DP=270	GT	0/1
chr3	160970622	160970622	G	C	exonic	NMD3	.	nonsynonymous SNV	NMD3:NM_001320227:exon17:c.G1558C:p.D520H	4.42E-05	0.991223131	0.008732642	.	0.07893	0.10797	-0.512444034	21.55579146	81.92408	1.91851	0.322	0.135	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	.	.	.	0.86	0.468	T	0.07	0.061	N	0.075	0.065	-1.001	0.297	T	0.086	0.336	T	0.006	0.160	T	-0.346	0.065	0.520	0.188	0.006	0.000	0.003	N	c	-1.240	-1.379	0.003	0.100	0.498	0.195	0	0.597	0.166	-0.191	0.095	-0.578	0.045	0.001	0.137	0.005	0.090	.	.	.	.	.	0.5	63	161	chr3	160970622	chr3:160970622	G	C	63	PASS	AN=2;DP=161	GT	0/1
chr3	179083024	179083024	-	T	intronic	MFN1	.	.	.	0.01903819	0.980927452	3.44E-05	.	0.82846	0.13128	-0.246069119	36.06982779	58.55807	1.55048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	383	chr3	179083024	chr3:179083024	A	AT	101	PASS	AN=2;DP=383	GT	0/1
chr3	179119110	179119110	-	A	intronic	GNB4	.	.	.	0.629775083	0.369918722	0.000306195	.	0.45415	0.12971	-0.029247611	51.40363293	17.25958	0.60544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	529	chr3	179119110	chr3:179119110	G	GA	79	PASS	AN=2;DP=529	GT	0/1
chr3	179333753	179333753	-	T	intronic	NDUFB5	.	.	.	0.003441089	0.835086357	0.161472554	.	0.10317	0.14954	0.147123112	64.11299835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	341	chr3	179333753	chr3:179333753	C	CT	62	PASS	AN=2;DP=341	GT	0/1
chr3	183400568	183400568	-	T	UTR3	KLHL24	NM_001349417:c.*3494_*3495insT;NM_001349420:c.*3494_*3495insT;NM_001349419:c.*3494_*3495insT;NM_001349418:c.*3494_*3495insT;NM_001349414:c.*3494_*3495insT;NM_001349413:c.*3494_*3495insT;NM_001349416:c.*3494_*3495insT;NM_001349415:c.*3494_*3495insT;NM_001349421:c.*3494_*3495insT;NM_001349423:c.*3494_*3495insT;NM_001349422:c.*3494_*3495insT;NM_001349427:c.*3494_*3495insT;NM_001349429:c.*3494_*3495insT;NM_001349428:c.*3494_*3495insT;NM_001349426:c.*3494_*3495insT;NM_001349425:c.*3494_*3495insT;NM_001349424:c.*3494_*3495insT;NM_017644:c.*3494_*3495insT	.	.	0.25241443	0.746312969	0.001272601	.	0.21414	0.11262	-0.780646273	12.77423921	734.84508	5.37741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	314	chr3	183400567	chr3:183400567	AT	ATT,A	82	PASS	AN=2;DP=314	GT	0/1
chr3	183400568	183400568	T	-	UTR3	KLHL24	NM_001349417:c.*3494delT;NM_001349420:c.*3494delT;NM_001349419:c.*3494delT;NM_001349418:c.*3494delT;NM_001349414:c.*3494delT;NM_001349413:c.*3494delT;NM_001349416:c.*3494delT;NM_001349415:c.*3494delT;NM_001349421:c.*3494delT;NM_001349423:c.*3494delT;NM_001349422:c.*3494delT;NM_001349427:c.*3494delT;NM_001349429:c.*3494delT;NM_001349428:c.*3494delT;NM_001349426:c.*3494delT;NM_001349425:c.*3494delT;NM_001349424:c.*3494delT;NM_017644:c.*3494delT	.	.	0.25241443	0.746312969	0.001272601	.	0.21414	0.11262	-0.780646273	12.77423921	734.84508	5.37741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	314	chr3	183400567	chr3:183400567	AT	ATT,A	82	PASS	AN=2;DP=314	GT	0/1
chr3	189705447	189705447	C	A	exonic	P3H2	.	nonsynonymous SNV	P3H2:NM_001134418:exon5:c.G424T:p.V142L,P3H2:NM_018192:exon5:c.G967T:p.V323L	.	.	.	.	0.14234	0.13152	-0.554717505	19.79830149	.	.	0.254	0.178	T	0.0	0.026	B	0.0	0.013	B	0.025	0.262	N	0.821	0.348	D	1.5	0.380	L	1.76	0.260	T	-0.97	0.258	N	0.141	0.168	-1.032	0.198	T	0.032	0.137	T	0.006	0.159	T	2.954	0.415	22.1	0.985	0.421	0.626	0.316	D	c	-0.577	-0.445	0.806	0.242	0.732	0.924	0	3.2	0.357	0.486	0.219	0.935	0.490	0.001	0.137	1.000	0.888	5.443	0.157	Tetratricopeptide-like helical domain	.	.	0.5	115	58	chr3	189705447	chr3:189705447	C	A	115	PASS	AN=2;DP=58	GT	0/1
chr3	195453249	195453249	T	C	exonic	MUC20	.	nonsynonymous SNV	MUC20:NM_001282506:exon2:c.T1775C:p.M592T,MUC20:NM_001291833:exon4:c.T1262C:p.M421T,MUC20:NM_020790:exon4:c.T1319C:p.M440T,MUC20:NM_152673:exon4:c.T1262C:p.M421T	.	.	.	.	.	0.05395	.	.	2482.91489	9.29408	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.830	0.091	N	1	0.206	N	-1.65	0.004	N	3.45	0.086	T	2.15	0.004	N	0.419	0.476	-0.954	0.403	T	0.007	0.026	T	.	.	.	-2.240	0.005	0.001	0.392	0.027	0.000	0.001	N	c	-1.579	-1.475	0.000	0.064	0.516	0.203	0	2.7	0.309	0.520	0.224	-2.118	0.004	0.000	0.063	0.000	0.016	7.490	0.265	.	.	.	0.5	.	140	chr3	195453249	chr3:195453249	T	C	.	PASS	AN=0;DP=140	GT	0/1
chr3	197577609	197577609	C	T	intronic	LRCH3	.	.	.	1.20E-08	0.984194783	0.015805205	.	0.25359	0.09814	-0.530852121	20.82448691	509.6375	4.62536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	666	chr3	197577609	chr3:197577609	C	T	72	PASS	AN=2;DP=666	GT	0/1
chr4	3769789	3769789	-	GGGGAGCTTTCCCAGAGACCC	UTR3	ADRA2C	NM_000683:c.*67_*68insGGGGAGCTTTCCCAGAGACCC	.	.	0.645951821	0.347840902	0.006207277	.	0.03325	0.09956	.	.	2173.15437	8.58195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	118	chr4	3769789	chr4:3769789	G	GGGGGAGCTTTCCCAGAGACCC	135	PASS	AN=2;DP=118	GT	0/1
chr4	6711493	6711493	-	T	UTR5	MRFAP1L1	NM_203462:c.-138_-137insA	.	.	0.008908008	0.578868963	0.412223029	.	0.16044	0.11262	0.125076652	62.7388535	42.65034	1.23741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	222	chr4	6711493	chr4:6711493	A	AT	64	PASS	AN=2;DP=222	GT	0/1
chr4	8472785	8472785	-	A	intronic	TRMT44	.	.	.	1.48E-13	0.006885759	0.993114241	.	0.11127	0.07994	.	.	301.17928	3.69794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	170	chr4	8472785	chr4:8472785	G	GA	66	PASS	AN=2;DP=170	GT	0/1
chr4	46314618	46314618	G	A	exonic	GABRA2	.	nonsynonymous SNV	GABRA2:NM_001114175:exon4:c.C371T:p.P124L,GABRA2:NM_001286827:exon4:c.C206T:p.P69L,GABRA2:NM_000807:exon5:c.C371T:p.P124L,GABRA2:NM_001330690:exon5:c.C371T:p.P124L	0.976963701	0.023031697	4.60E-06	.	0.31694	0.13475	-0.273576253	33.97027601	19.24152	0.66325	0.0	0.912	D	0.999	0.899	D	0.98	0.971	D	0.000	0.843	D	1	0.810	D	3.72	0.949	H	-5.0	0.985	D	-9.21	0.983	D	0.732	0.978	1.055	0.982	D	0.981	0.994	D	0.365	0.926	D	6.582	0.905	31	0.998	0.925	0.991	0.910	D	c	1.149	1.073	1.000	0.747	0.487	0.133	0	5.95	0.964	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	19.363	0.944	Neurotransmitter-gated ion-channel ligand-binding domain	.	.	0.5	123	52	chr4	46314618	chr4:46314618	G	A	123	PASS	AN=2;DP=52	GT	0/1
chr4	78806528	78806528	-	T	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	42	chr4	78806528	chr4:78806528	A	AT	70	PASS	AN=2;DP=42	GT	0/1
chr4	78815273	78815273	-	T	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	133	chr4	78815272	chr4:78815272	CT	CTT,C	71	PASS	AN=2;DP=133	GT	0/1
chr4	78815273	78815273	T	-	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	133	chr4	78815272	chr4:78815272	CT	CTT,C	71	PASS	AN=2;DP=133	GT	0/1
chr4	79102082	79102082	C	T	intronic	FRAS1	.	.	.	2.29E-23	0.999999999	7.91E-10	DISEASE: Fraser syndrome (FRASS) [MIM:219000]: Multisystem malformation usually comprising cryptophthalmos, cutaneous syndactyly, ear abnormalities, renal agenesis and congenital heart defects. {ECO:0000269|PubMed:23473829}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59318	0.10946	4.646228703	99.76999292	7813.79024	19.03935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	672	chr4	79102082	chr4:79102082	C	T	79	PASS	AN=2;DP=672	GT	0/1
chr4	95198159	95198159	A	C	intronic	SMARCAD1	.	.	.	0.999996803	3.20E-06	1.79E-15	.	0.31853	0.24651	0.266447942	70.5826846	3025.83606	10.4458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	78	chr4	95198159	chr4:95198159	A	C	74	PASS	AN=2;DP=78	GT	0/1
chr4	110737293	110737293	-	T	intronic	GAR1	.	.	.	0.81256498	0.187235181	0.000199839	.	0.15921	0.12543	0.347360312	73.97381458	48.13207	1.35139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	332	chr4	110737293	chr4:110737293	G	GT	79	PASS	AN=2;DP=332	GT	0/1
chr4	141446575	141446575	A	-	UTR5	ELMOD2	NM_153702:c.-8del-	.	.	0.804445978	0.195329266	0.000224756	.	0.35237	0.11956	0.193034296	66.82000472	54.66599	1.47966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	104	chr4	141446574	chr4:141446574	GA	G	59	PASS	AN=2;DP=104	GT	0/1
chr4	141481204	141481204	T	-	intronic	UCP1	.	.	.	4.52E-08	0.114065456	0.885934498	.	0.17669	0.5878	0.196671391	67.19155461	861.30815	5.72408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.49	94	chr4	141481203	chr4:141481203	AT	A	11.49	PASS	AN=0;DP=94	GT	0/1
chr4	158281848	158281848	-	T	intronic	GRIA2	.	.	.	0.99550949	0.004490506	3.42E-09	.	0.3057	0.25829	-0.778825328	12.88039632	32.84712	1.01918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	104	chr4	158281848	chr4:158281848	G	GT	81	PASS	AN=2;DP=104	GT	0/1
chr4	174253277	174253279	TCC	-	exonic	HMGB2	.	nonframeshift deletion	HMGB2:NM_001130689:exon4:c.582_584del:p.E197del,HMGB2:NM_001130688:exon5:c.582_584del:p.E197del,HMGB2:NM_002129:exon5:c.582_584del:p.E197del	0.907849743	0.091424126	0.00072613	.	0.93997	0.22063	-0.031067188	51.03798066	28.58852	0.91569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	50	chr4	174253276	chr4:174253276	TTCC	T	54	PASS	AN=2;DP=50	GT	0/1
chr5	63507969	63507969	A	C	exonic	RNF180	.	synonymous SNV	RNF180:NM_001113561:exon3:c.A213C:p.I71I,RNF180:NM_001323291:exon3:c.A213C:p.I71I,RNF180:NM_001323292:exon3:c.A213C:p.I71I,RNF180:NM_178532:exon3:c.A213C:p.I71I	5.17E-05	0.672649596	0.32729867	.	0.41298	0.07689	0.108486928	61.90728946	571.53785	4.85009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	145	chr5	63507969	chr5:63507969	A	C	135	PASS	AN=2;DP=145	GT	0/1
chr5	68875556	68875556	-	T	intronic	GTF2H2C;GTF2H2C_2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	123	chr5	68875556	chr5:68875556	G	GT	65	PASS	AN=2;DP=123	GT	0/1
chr5	69730714	69730714	-	T	ncRNA_intronic	GTF2H2B;GUSBP3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	165	chr5	69730714	chr5:69730714	G	GT	76	PASS	AN=2;DP=165	GT	0/1
chr5	80088493	80088493	-	T	intronic	MSH3	.	.	.	4.57E-23	0.002294752	0.997705248	DISEASE: Endometrial cancer (ENDMC) [MIM:608089]: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids. {ECO:0000305|PubMed:8782829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47698	0.19216	-0.079012906	47.25760793	3510.45198	11.4303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	31	chr5	80088493	chr5:80088493	G	GT	67	PASS	AN=2;DP=31	GT	0/1
chr5	121187815	121187815	G	A	exonic	FTMT	.	nonsynonymous SNV	FTMT:NM_177478:exon1:c.G157A:p.A53T	0.081623987	0.756095225	0.162280788	.	0.06302	0.20458	0.371224249	75.12384996	105.36958	2.22323	0.193	0.209	T	0.014	0.156	B	0.002	0.063	B	.	.	.	1	0.090	N	1.05	0.269	L	-0.05	0.634	T	-0.73	0.206	N	0.061	0.045	-1.040	0.173	T	0.106	0.387	T	0.034	0.552	D	0.490	0.141	7.352	0.982	0.389	0.037	0.089	N	c	-1.141	-1.219	0.000	0.029	0.487	0.133	0	-1.73	0.076	-0.049	0.118	-0.235	0.093	0.000	0.063	0.000	0.016	2.593	0.045	.	.	.	0.5	.	110	chr5	121187815	chr5:121187815	G	A	.	PASS	AN=0;DP=110	GT	0/1
chr5	177099140	177099140	T	A	ncRNA_exonic	LOC202181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	103	chr5	177099140	chr5:177099140	T	A	104	PASS	AN=2;DP=103	GT	0/1
chr5	180058748	180058748	G	-	exonic	FLT4	.	frameshift deletion	FLT4:NM_002020:exon2:c.89delC:p.P30Rfs*2,FLT4:NM_182925:exon2:c.89delC:p.P30Rfs*2	0.999936679	6.33E-05	4.32E-15	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	500	chr5	180058747	chr5:180058747	CG	C	77	PASS	AN=2;DP=500	GT	0/1
chr6	26406255	26406255	G	A	exonic	BTN3A1	.	synonymous SNV	BTN3A1:NM_001145008:exon3:c.G204A:p.V68V,BTN3A1:NM_001145009:exon3:c.G204A:p.V68V,BTN3A1:NM_007048:exon3:c.G204A:p.V68V,BTN3A1:NM_194441:exon3:c.G204A:p.V68V	8.65E-07	0.747593221	0.252405913	.	0.06787	0.07707	0.531004228	80.87992451	647.15095	5.10575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	183	chr6	26406255	chr6:26406255	G	A	.	PASS	AN=0;DP=183	GT	0/1
chr6	28352670	28352670	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15716;dist=4057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	143	chr6	28352670	chr6:28352670	C	G	52	PASS	AN=2;DP=143	GT	0/1
chr6	28352758	28352758	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15804;dist=3969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	113	chr6	28352758	chr6:28352758	C	G	81	PASS	AN=2;DP=113	GT	0/1
chr6	37427378	37427378	G	A	exonic	CMTR1	.	nonsynonymous SNV	CMTR1:NM_015050:exon10:c.G1013A:p.R338H	0.999294924	0.000705076	7.57E-12	.	0.3161	0.11198	-1.087493118	7.106628922	28.34808	0.90802	0.161	0.272	T	1.0	0.899	D	0.945	0.664	D	0.000	0.843	D	1	0.810	D	-0.115	0.046	N	0.97	0.425	T	-1.12	0.289	N	0.762	0.766	-1.009	0.271	T	0.103	0.379	T	0.012	0.313	T	6.359	0.878	29.4	0.999	0.999	0.988	0.868	D	c	0.597	0.689	1.0	0.983	0.722	0.854	0	6.17	0.997	6.324	0.727	1.048	0.713	1.000	0.715	1.000	0.888	19.868	0.968	Ribosomal RNA methyltransferase FtsJ domain|RrmJ-type ribose 2-O-methyltransferase domain|S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	98	110	chr6	37427378	chr6:37427378	G	A	98	PASS	AN=2;DP=110	GT	0/1
chr6	50681703	50681703	-	T	UTR5	TFAP2D	NM_172238:c.-66_-65insT	.	.	0.981586998	0.018399928	1.31E-05	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	479	chr6	50681703	chr6:50681703	A	AT	86	PASS	AN=2;DP=479	GT	0/1
chr6	89601638	89601638	T	A	intronic	RNGTT	.	.	.	0.763456431	0.236540369	3.20E-06	.	0.84113	0.19698	-0.558357437	19.54470394	54.7413	1.48185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	128	chr6	89601638	chr6:89601638	T	A	52	PASS	AN=2;DP=128	GT	0/1
chr6	107474777	107474777	-	A	UTR3	PDSS2	NM_020381:c.*1045_*1046insT	.	.	1.90E-05	0.695884938	0.304096105	DISEASE: Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. {ECO:0000269|PubMed:17186472}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07675	0.11464	-0.069700724	48.54328851	310.44253	3.74923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	48	chr6	107474777	chr6:107474777	G	GA	55	PASS	AN=2;DP=48	GT	0/1
chr6	133119524	133119524	G	A	intronic	SLC18B1	.	.	.	3.95E-10	0.179498685	0.820501314	.	0.13733	.	-0.110153916	45.48832272	589.95485	4.92467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	236	chr6	133119524	chr6:133119524	G	A	125	PASS	AN=2;DP=236	GT	0/1
chr6	134490613	134490613	-	A	UTR3	SGK1	NM_001143678:c.*792_*793insT;NM_005627:c.*792_*793insT;NM_001291995:c.*792_*793insT;NM_001143677:c.*792_*793insT;NM_001143676:c.*792_*793insT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	24.58	60	chr6	134490613	chr6:134490613	C	CA	24.58	PASS	AN=0;DP=60	GT	0/1
chr6	134758928	134758932	TCCTT	-	ncRNA_exonic	LINC01010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	137	chr6	134758927	chr6:134758927	GTCCTT	G	118	PASS	AN=2;DP=137	GT	0/1
chr6	136582417	136582417	G	A	exonic	BCLAF1	.	nonsynonymous SNV	BCLAF1:NM_001077440:exon11:c.C2590T:p.R864C,BCLAF1:NM_001077441:exon12:c.C2224T:p.R742C,BCLAF1:NM_001301038:exon12:c.C2737T:p.R913C,BCLAF1:NM_014739:exon12:c.C2743T:p.R915C	.	.	.	.	0.85841	0.18154	1.987926294	97.63505544	3652.78199	11.74717	0.032	0.469	D	1.0	0.899	D	0.988	0.850	D	0.000	0.629	D	1.000	0.588	D	0	0.065	N	4.26	0.161	T	-1.2	0.320	N	0.874	0.863	-0.997	0.309	T	0.084	0.329	T	.	.	.	4.562	0.611	24.4	0.992	0.542	0.972	0.729	D	c	0.262	0.417	1.000	0.747	0.707	0.730	0	5.71	0.890	5.465	0.662	1.048	0.713	1.000	0.715	1.000	0.888	18.034	0.892	.	.	.	0.5	99	83	chr6	136582417	chr6:136582417	G	A	99	PASS	AN=2;DP=83	GT	0/1
chr7	6470058	6470058	-	T	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	119	chr7	6470058	chr7:6470058	C	CT	80	PASS	AN=2;DP=119	GT	0/1
chr7	21747481	21747481	-	T	intronic	DNAH11	.	.	.	.	.	.	DISEASE: Kartagener syndrome (KTGS) [MIM:244400]: An autosomal recessive disorder characterized by the association of primary ciliary dyskinesia with situs inversus. Clinical features include recurrent respiratory infections, bronchiectasis, infertility, and lateral transposition of the viscera of the thorax and abdomen. The situs inversus is most often total, although it can be partial in some cases (isolated dextrocardia or isolated transposition of abdominal viscera). {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia; reduced fertility is often observed in male patients due to abnormalities of sperm tails. Half of the patients exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12513	0.12171	.	.	20704.35568	30.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	122	chr7	21747481	chr7:21747481	A	AT	66	PASS	AN=2;DP=122	GT	0/1
chr7	26247985	26247985	T	-	intronic	CBX3	.	.	.	0.633200403	0.359860988	0.006938609	.	0.65881	0.2066	0.057118534	57.99716914	6.1306	0.23144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	67	chr7	26247984	chr7:26247984	CT	C	106	PASS	AN=2;DP=67	GT	0/1
chr7	42000586	42000586	-	T	UTR3	GLI3	NM_000168:c.*3341_*3342insA	.	.	0.999994739	5.26E-06	6.01E-15	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9964	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	568	chr7	42000586	chr7:42000586	A	AT	61	PASS	AN=2;DP=568	GT	0/1
chr7	47979921	47979921	A	-	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	100	chr7	47979920	chr7:47979920	GA	G	81	PASS	AN=2;DP=100	GT	0/1
chr7	55268916	55268916	C	T	exonic	EGFR	.	synonymous SNV	EGFR:NM_001346941:exon19:c.C2181T:p.D727D,EGFR:NM_001346897:exon24:c.C2847T:p.D949D,EGFR:NM_001346899:exon24:c.C2847T:p.D949D,EGFR:NM_001346898:exon25:c.C2982T:p.D994D,EGFR:NM_001346900:exon25:c.C2823T:p.D941D,EGFR:NM_005228:exon25:c.C2982T:p.D994D	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	541	chr7	55268916	chr7:55268916	C	T	.	PASS	AN=0;DP=541	GT	0/1
chr7	63225779	63225779	C	T	intergenic	MIR4283-1;ZNF722P	dist=144232;dist=233405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	171	chr7	63225779	chr7:63225779	C	T	122	PASS	AN=2;DP=171	GT	0/1
chr7	63537783	63537783	G	A	exonic	ZNF727	.	nonsynonymous SNV	ZNF727:NM_001159522:exon4:c.G356A:p.R119H	1.56E-07	0.065227374	0.93477247	.	.	.	2.34827224	98.40764331	260.10396	3.46546	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	1.51	0.383	L	.	.	.	.	.	.	0.041	0.021	-0.923	0.452	T	0.000	0.000	T	.	.	.	0.297	0.123	5.666	0.811	0.131	0.000	0.004	N	c	-1.681	-1.761	0.000	0.064	0.487	0.133	0	-1.15	0.092	-0.122	0.105	-0.609	0.043	0.000	0.063	0.079	0.180	.	.	.	.	.	0.5	129	278	chr7	63537783	chr7:63537783	G	A	129	PASS	AN=2;DP=278	GT	0/1
chr7	66463196	66463196	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	200	chr7	66463195	chr7:66463195	AT	A	70	PASS	AN=2;DP=200	GT	0/1
chr7	66703239	66703239	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	304	chr7	66703238	chr7:66703238	AT	A,ATT	53	PASS	AN=2;DP=304	GT	0/1
chr7	66703239	66703239	-	T	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	304	chr7	66703238	chr7:66703238	AT	A,ATT	53	PASS	AN=2;DP=304	GT	0/1
chr7	100460331	100460331	G	A	exonic	SLC12A9	.	synonymous SNV	SLC12A9:NM_001267814:exon11:c.G1473A:p.P491P,SLC12A9:NM_001267812:exon13:c.G1740A:p.P580P,SLC12A9:NM_020246:exon13:c.G1740A:p.P580P	2.37E-06	0.976967908	0.02302972	.	0.23194	0.15806	-1.168429872	6.062750649	76.20765	1.82962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	89	chr7	100460331	chr7:100460331	G	A	.	PASS	AN=0;DP=89	GT	0/1
chr7	107392911	107392911	C	G	intronic	CBLL1	.	.	.	0.997784848	0.002215079	7.36E-08	.	0.29297	0.11049	-0.516085732	21.20193442	14.90934	0.5368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	61	chr7	107392911	chr7:107392911	C	G	58	PASS	AN=2;DP=61	GT	0/1
chr7	121699790	121699790	T	-	intronic	PTPRZ1	.	.	.	0.994707963	0.005292037	7.09E-14	.	0.41776	0.27352	-2.216367922	1.350554376	7148.28548	18.18568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	69	chr7	121699789	chr7:121699789	CT	C,CTT	82	PASS	AN=2;DP=69	GT	0/1
chr7	121699790	121699790	-	T	intronic	PTPRZ1	.	.	.	0.994707963	0.005292037	7.09E-14	.	0.41776	0.27352	-2.216367922	1.350554376	7148.28548	18.18568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	69	chr7	121699789	chr7:121699789	CT	C,CTT	82	PASS	AN=2;DP=69	GT	0/1
chr7	122194609	122194609	A	G	exonic	CADPS2	.	synonymous SNV	CADPS2:NM_001009571:exon8:c.T1470C:p.H490H,CADPS2:NM_001167940:exon8:c.T1470C:p.H490H,CADPS2:NM_017954:exon8:c.T1470C:p.H490H	0.997778954	0.002221046	5.08E-12	.	0.45062	0.12261	-0.661316159	16.02382637	194.52292	3.0232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	135	chr7	122194609	chr7:122194609	A	G	128	PASS	AN=2;DP=135	GT	0/1
chr7	148106465	148106465	-	TCTT	intronic	CNTNAP2	.	.	.	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	185	chr7	148106465	chr7:148106465	C	CTCTT	119	PASS	AN=2;DP=185	GT	0/1
chr7	149489467	149489467	G	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon37:c.G5620A:p.G1874S	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	1.0	0.899	D	0.999	0.916	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.42	0.477	.	.	.	.	.	.	.	.	.	0.316	0.124	5.852	0.672	0.080	0.958	0.661	D	n	1.283	2.151	0.999	0.392	0.078	0.016	0	4.13	0.475	2.601	0.457	1.048	0.713	0.973	0.343	0.005	0.090	12.914	0.574	VWC out|VWFC domain	.	.	0.5	70	412	chr7	149489467	chr7:149489467	G	A	70	PASS	AN=2;DP=412	GT	0/1
chr8	38645040	38645040	A	-	UTR5	TACC1	NM_006283:c.-61del-;NM_001122824:c.-61del-	.	.	0.015120874	0.984640575	0.00023855	.	0.18153	0.10845	-0.639268965	16.70794999	84.23672	1.95388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	2453	chr8	38645039	chr8:38645039	GA	G	120	PASS	AN=2;DP=2453	GT	0/1
chr8	52733023	52733023	T	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.A734G:p.N245S,PCMTD1:NM_001286783:exon6:c.A434G:p.N145S,PCMTD1:NM_052937:exon6:c.A962G:p.N321S	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.739	0.059	T	0.0	0.026	B	0.0	0.013	B	0.758	0.065	N	0.999	0.217	N	1.04	0.263	L	1.6	0.421	T	0.05	0.064	N	0.041	0.021	-1.001	0.297	T	0.036	0.153	T	.	.	.	-2.130	0.006	0.001	0.580	0.058	0.445	0.271	N	c	-1.086	-0.938	0.982	0.303	0.707	0.730	0	2.0	0.254	0.127	0.155	-0.448	0.056	0.924	0.318	0.161	0.208	2.389	0.041	.	.	.	0.5	116	151	chr8	52733023	chr8:52733023	T	C	116	PASS	AN=2;DP=151	GT	0/1
chr8	53535765	53535765	T	-	UTR3	RB1CC1	NM_014781:c.*577delA;NM_001083617:c.*577delA	.	.	0.999999799	2.01E-07	4.29E-19	.	0.82038	0.21518	-1.587406381	3.113941967	234.10831	3.30711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	21	chr8	53535764	chr8:53535764	CT	C	72	PASS	AN=2;DP=21	GT	0/1
chr8	62555482	62555482	-	A	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	111	chr8	62555482	chr8:62555482	G	GA	55	PASS	AN=2;DP=111	GT	0/1
chr8	68112596	68112596	G	A	intronic	ARFGEF1	.	.	.	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	0.13	0.267	T	.	.	.	.	.	.	.	.	.	1	0.182	N	.	.	.	0.88	0.460	T	-0.58	0.174	N	0.108	0.115	-1.010	0.268	T	0.040	0.171	T	0.003	0.078	T	0.251	0.118	5.206	0.720	0.095	0.113	0.163	N	c	-0.687	-0.836	0.006	0.112	0.707	0.730	0	1.75	0.236	0.014	0.131	-0.415	0.060	0.000	0.063	0.001	0.043	5.222	0.146	.	.	.	0.5	107	156	chr8	68112596	chr8:68112596	G	A	107	PASS	AN=2;DP=156	GT	0/1
chr8	128429315	128429315	T	A	ncRNA_intronic	CASC8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	125	chr8	128429315	chr8:128429315	T	A	100	PASS	AN=2;DP=125	GT	0/1
chr9	73247	73247	C	T	ncRNA_intronic	PGM5P3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	244	chr9	73247	chr9:73247	C	T	87	PASS	AN=2;DP=244	GT	0/1
chr9	146032	146032	C	A	intronic	CBWD1	.	.	.	0.642141452	0.356513512	0.001345035	.	0.1465	0.09079	.	.	228.50043	3.26546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	28	chr9	146032	chr9:146032	C	A	51	PASS	AN=2;DP=28	GT	0/1
chr9	5811338	5811338	A	-	intronic	ERMP1	.	.	.	4.55E-05	0.998228722	0.001725778	.	0.17248	0.09494	-1.03976177	7.802547771	243.10681	3.36551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	34	chr9	5811337	chr9:5811337	CA	C	78	PASS	AN=2;DP=34	GT	0/1
chr9	33469406	33469406	C	T	intronic	NOL6	.	.	.	0.999078032	0.000921968	2.94E-12	.	0.21138	0.11067	-0.231522913	36.36470866	535.96118	4.71978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	53	chr9	33469406	chr9:33469406	C	T	84	PASS	AN=2;DP=53	GT	0/1
chr9	36344900	36344900	C	T	exonic	RNF38	.	synonymous SNV	RNF38:NM_194329:exon9:c.G1164A:p.L388L,RNF38:NM_194332:exon9:c.G1065A:p.L355L,RNF38:NM_022781:exon10:c.G1314A:p.L438L,RNF38:NM_194328:exon10:c.G1065A:p.L355L,RNF38:NM_194330:exon10:c.G1065A:p.L355L	0.999390257	0.000609742	6.41E-10	.	0.5568	0.11262	-0.471992905	23.03609342	10.65785	0.3869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	92	chr9	36344900	chr9:36344900	C	T	52	PASS	AN=2;DP=92	GT	0/1
chr9	66457628	66457628	G	A	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	169	chr9	66457628	chr9:66457628	G	A	106	PASS	AN=2;DP=169	GT	0/1
chr9	69830318	69830318	G	A	intergenic	LOC101928381;FOXD4L5	dist=72534;dist=345389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	745	chr9	69830318	chr9:69830318	G	A	128	PASS	AN=2;DP=745	GT	0/1
chr9	79119830	79119830	T	-	UTR3	GCNT1	NM_001097634:c.*1246delT;NM_001490:c.*1246delT;NM_001097633:c.*1246delT;NM_001097635:c.*1246delT;NM_001097636:c.*1246delT	.	.	0.066576637	0.871276331	0.062147032	.	0.09236	0.15899	0.374860183	75.43052607	1448.65204	7.10058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	32	chr9	79119829	chr9:79119829	AT	A	78	PASS	AN=2;DP=32	GT	0/1
chr9	116155669	116155669	-	CCCCAA	intronic	ALAD	.	.	.	0.06295026	0.933785175	0.003264564	DISEASE: Acute hepatic porphyria (AHEPP) [MIM:612740]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. {ECO:0000269|PubMed:10706561, ECO:0000269|PubMed:1309003, ECO:0000269|PubMed:1569184, ECO:0000269|PubMed:2063868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11936	0.55928	-0.558357437	19.54470394	471.54569	4.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	77	chr9	116155669	chr9:116155669	T	TCCCCAA	126	PASS	AN=2;DP=77	GT	0/1
chr9	116172489	116172489	C	-	intronic	POLE3	.	.	.	0.077745399	0.751043147	0.171211454	.	0.34686	0.24974	-0.119252484	44.53880632	8.01565	0.29467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	1548	chr9	116172488	chr9:116172488	GC	G,GCC	108	PASS	AN=2;DP=1548	GT	0/1
chr9	116172489	116172489	-	C	intronic	POLE3	.	.	.	0.077745399	0.751043147	0.171211454	.	0.34686	0.24974	-0.119252484	44.53880632	8.01565	0.29467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	1548	chr9	116172488	chr9:116172488	GC	G,GCC	108	PASS	AN=2;DP=1548	GT	0/1
chr9	118228115	118228115	-	G	intergenic	DEC1;LOC101928775	dist=63192;dist=273834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	82	chr9	118228115	chr9:118228115	A	AG	136	PASS	AN=2;DP=82	GT	0/1
chr9	130869493	130869493	G	-	intronic	SLC25A25	.	.	.	0.973302049	0.026691324	6.63E-06	.	0.11945	0.09594	-0.44448505	24.46331682	56.75648	1.51571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	506	chr9	130869492	chr9:130869492	CG	C	65	PASS	AN=2;DP=506	GT	0/1
chr10	35360310	35360310	G	A	intronic	CUL2	.	.	.	0.99999841	1.59E-06	1.61E-15	.	0.72401	0.19444	-0.580403979	18.58928993	30.29769	0.96644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	36	chr10	35360310	chr10:35360310	G	A	55	PASS	AN=2;DP=36	GT	0/1
chr10	79628875	79628875	A	G	intronic	DLG5	.	.	.	0.999998542	1.46E-06	2.19E-18	.	0.27889	0.16537	-2.369063868	1.126444916	774.17189	5.50725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	149	chr10	79628875	chr10:79628875	A	G	99	PASS	AN=2;DP=149	GT	0/1
chr10	101959818	101959818	T	C	intronic	CHUK	.	.	.	0.998703705	0.001296295	1.65E-10	DISEASE: Cocoon syndrome (COCOS) [MIM:613630]: A lethal syndrome characterized by multiple fetal malformations including defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. {ECO:0000269|PubMed:20961246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84106	0.63405	-0.201976964	38.98325077	135.45191	2.53221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	50	chr10	101959818	chr10:101959818	T	C	97	PASS	AN=2;DP=50	GT	1/0
chr10	119764587	119764587	C	A	UTR3	RAB11FIP2	NM_014904:c.*3922G>T;NM_001330167:c.*3922G>T	.	.	0.910707841	0.089154579	0.000137579	.	0.32279	0.13177	0.086440867	60.47416844	470.93745	4.49152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	36	chr10	119764587	chr10:119764587	C	A	70	PASS	AN=2;DP=36	GT	1/0
chr10	127789606	127789606	T	-	intronic	ADAM12	.	.	.	0.341608447	0.658390535	1.02E-06	.	0.65368	0.23183	0.009173042	54.15782024	245.04565	3.37758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	145	chr10	127789605	chr10:127789605	CT	C	71	PASS	AN=2;DP=145	GT	0/1
chr11	373427	373427	C	T	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	85	chr11	373427	chr11:373427	C	T	91	PASS	AN=2;DP=85	GT	0/1
chr11	4159457	4159457	A	G	exonic	RRM1	.	synonymous SNV	RRM1:NM_001318065:exon13:c.A1209G:p.T403T,RRM1:NM_001330193:exon13:c.A1557G:p.T519T,RRM1:NM_001318064:exon18:c.A1932G:p.T644T,RRM1:NM_001033:exon19:c.A2223G:p.T741T	0.999994804	5.20E-06	2.88E-14	.	0.9905	0.35194	-0.644723694	16.52512385	49.59769	1.37845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	43	chr11	4159457	chr11:4159457	A	G	105	PASS	AN=2;DP=43	GT	0/1
chr11	18600278	18600278	G	A	exonic	UEVLD	.	synonymous SNV	UEVLD:NM_001040697:exon2:c.C120T:p.D40D,UEVLD:NM_001261382:exon2:c.C120T:p.D40D,UEVLD:NM_001261383:exon2:c.C120T:p.D40D,UEVLD:NM_001261385:exon2:c.C6T:p.D2D,UEVLD:NM_001261386:exon2:c.C120T:p.D40D,UEVLD:NM_001297771:exon2:c.C120T:p.D40D,UEVLD:NM_018314:exon2:c.C120T:p.D40D	1.09E-07	0.542920198	0.457079693	.	0.13244	0.14875	-0.402212257	26.7338995	286.11158	3.6211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	51	chr11	18600278	chr11:18600278	G	A	82	PASS	AN=2;DP=51	GT	0/1
chr11	47204533	47204533	C	-	intronic	PACSIN3	.	.	.	0.016793048	0.978273746	0.004933206	.	0.49122	0.20173	-0.532670911	20.78320359	1052.93556	6.23032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	368	chr11	47204532	chr11:47204532	TC	T	91	PASS	AN=2;DP=368	GT	0/1
chr11	49860159	49860159	-	T	intergenic	LOC440040;OR4C13	dist=28190;dist=113784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	397	chr11	49860158	chr11:49860158	AT	ATT,A	74	PASS	AN=2;DP=397	GT	0/1
chr11	49860159	49860159	T	-	intergenic	LOC440040;OR4C13	dist=28190;dist=113784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	397	chr11	49860158	chr11:49860158	AT	ATT,A	74	PASS	AN=2;DP=397	GT	0/1
chr11	55579182	55579182	A	G	exonic	OR5L1	.	synonymous SNV	OR5L1:NM_001004738:exon1:c.A240G:p.K80K	5.94E-07	0.039026869	0.960972537	.	0.06073	0.09152	0.795569043	87.49115357	1193.77829	6.55439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	267	chr11	55579182	chr11:55579182	A	G	102	PASS	AN=2;DP=267	GT	0/1
chr11	58381664	58381664	T	-	ncRNA_intronic	ZFP91-CNTF	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	109	chr11	58381663	chr11:58381663	AT	A	65	PASS	AN=2;DP=109	GT	0/1
chr11	64457918	64457918	-	C	exonic	NRXN2	.	frameshift insertion	NRXN2:NM_015080:exon5:c.808dupG:p.A270Gfs*26	0.999895574	0.000104426	7.22E-14	.	0.24191	0.10189	-2.164449385	1.427223402	1296.88776	6.77694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	968	chr11	64457918	chr11:64457918	G	GC	96	PASS	AN=2;DP=968	GT	0/1
chr11	75134961	75134961	-	C	intronic	KLHL35	.	.	.	1.35E-12	0.001844037	0.998155963	.	.	0.11511	.	.	89.19671	2.02976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	chr11	75134960	chr11:75134960	GC	GCC,G	78	PASS	AN=2;DP=335	GT	0/1
chr11	75134961	75134961	C	-	intronic	KLHL35	.	.	.	1.35E-12	0.001844037	0.998155963	.	.	0.11511	.	.	89.19671	2.02976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	chr11	75134960	chr11:75134960	GC	GCC,G	78	PASS	AN=2;DP=335	GT	0/1
chr11	77639466	77639466	A	G	exonic	INTS4	.	synonymous SNV	INTS4:NM_033547:exon11:c.T1293C:p.S431S	0.653071264	0.346928651	8.43E-08	.	0.16947	0.15282	-0.576764155	18.7839113	270.96358	3.52905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	chr11	77639466	chr11:77639466	A	G	.	PASS	AN=0;DP=73	GT	0/1
chr11	124015941	124015941	C	T	intronic	VWA5A	.	.	.	1.89E-15	0.026741774	0.973258226	.	0.04851	.	0.648517637	84.14720453	1165.38867	6.49454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	166	chr11	124015941	chr11:124015941	C	T	123	PASS	AN=2;DP=166	GT	0/1
chr11	124096173	124096173	T	C	exonic	OR8G2P	.	nonsynonymous SNV	OR8G2P:NM_001291438:exon1:c.T776C:p.L259S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	237	chr11	124096173	chr11:124096173	T	C	99	PASS	AN=2;DP=237	GT	0/1
chr11	124951303	124951303	-	T	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	282	chr11	124951303	chr11:124951303	A	AT	76	PASS	AN=2;DP=282	GT	0/1
chr11	134078848	134078848	A	-	intronic	NCAPD3	.	.	.	0.073152087	0.926847913	2.97E-10	.	0.21247	0.0997	-0.374974929	28.11983958	451.0484	4.41414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	29	chr11	134078847	chr11:134078847	TA	T	54	PASS	AN=2;DP=29	GT	0/1
chr12	3728437	3728437	C	T	exonic	CRACR2A	.	synonymous SNV	CRACR2A:NM_001144958:exon18:c.G2034A:p.T678T	.	.	.	.	0.10919	0.10015	1.846456612	97.11606511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	208	chr12	3728437	chr12:3728437	C	T	.	PASS	AN=0;DP=208	GT	0/1
chr12	11183752	11183752	T	C	exonic	TAS2R31	.	synonymous SNV	TAS2R31:NM_176885:exon1:c.A183G:p.V61V	2.54E-05	0.174294483	0.82568008	.	.	.	2.195683333	98.11276244	1586.0821	7.36714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	180	chr12	11183752	chr12:11183752	T	C	92	PASS	AN=2;DP=180	GT	0/1
chr12	26834804	26834804	-	ACTC	intronic	ITPR2	.	.	.	5.74E-11	1	2.30E-12	DISEASE: Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190]: An autosomal recessive disorder characterized by generalized, isolated anhidrosis, severe heat intolerance, and morphologically normal eccrine sweat glands. Body growth, teeth, hair, nails, and skin are normal. {ECO:0000269|PubMed:25329695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90112	0.20622	-1.641009998	2.777777778	698.25496	5.25954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	39	chr12	26834804	chr12:26834804	T	TACTC	98	PASS	AN=2;DP=39	GT	0/1
chr12	50042048	50042048	G	A	exonic	FMNL3	.	synonymous SNV	FMNL3:NM_198900:exon21:c.C2451T:p.S817S,FMNL3:NM_175736:exon22:c.C2604T:p.S868S	0.356499504	0.643500313	1.83E-07	.	0.12501	0.10847	-1.017713296	8.103326256	188.83904	2.98373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	329	chr12	50042048	chr12:50042048	G	A	66	PASS	AN=2;DP=329	GT	0/1
chr12	51796890	51796941	TTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	-	intronic	SLC4A8	.	.	.	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	51	chr12	51796889	chr12:51796889	ATTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	A	114	PASS	AN=2;DP=51	GT	0/1
chr12	57522680	57522680	G	-	UTR5	LRP1	NM_002332:c.-68del-	.	.	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	527	chr12	57522679	chr12:57522679	TG	T	75	PASS	AN=2;DP=527	GT	0/1
chr12	91340253	91340253	T	-	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	106	chr12	91340252	chr12:91340252	CT	C,CTT	65	PASS	AN=2;DP=106	GT	0/1
chr12	91340253	91340253	-	T	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	106	chr12	91340252	chr12:91340252	CT	C,CTT	65	PASS	AN=2;DP=106	GT	0/1
chr12	102301162	102301162	-	T	intronic	DRAM1	.	.	.	0.080700077	0.872050796	0.047249127	.	.	.	-0.229483771	36.86010852	8.7844	0.32424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	142	chr12	102301162	chr12:102301162	G	GT	80	PASS	AN=2;DP=142	GT	0/1
chr12	116397416	116397416	C	T	UTR3	MED13L	NM_015335:c.*1655G>A	.	.	0.999999999	1.32E-09	2.08E-24	DISEASE: Note=A chromosomal aberration involving MED13L is found in a patient with transposition of the great arteries, dextro- looped and mental retardation. Translocation t(12;17)(q24.1;q21). {ECO:0000269|PubMed:14638541}.; 	0.80264	0.11567	-2.736273894	0.690021231	206.98599	3.10912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	75	chr12	116397416	chr12:116397416	C	T	76	PASS	AN=2;DP=75	GT	0/1
chr12	121676365	121676365	-	A	UTR3	CAMKK2	NM_153500:c.*2234_*2235insT;NM_006549:c.*2136_*2137insT;NM_172226:c.*2234_*2235insT;NM_001270485:c.*2136_*2137insT;NM_172216:c.*2136_*2137insT;NM_001270486:c.*1905_*1906insT;NM_153499:c.*2234_*2235insT	.	.	0.503475917	0.496488678	3.54E-05	.	0.5179	0.23396	-0.26629572	34.81953291	2630.25871	9.61927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	115	chr12	121676365	chr12:121676365	G	GA	71	PASS	AN=2;DP=115	GT	0/1
chr13	20242494	20242494	-	ACGTACTATTTTTTTTTCTTAGACTTTCAAGAGTAGCAGAAGAGACAATAAAGGATT	intronic	MPHOSPH8	.	.	.	0.930242309	0.069757082	6.08E-07	.	0.10351	0.09166	-0.242430445	36.22906346	300.14804	3.69378	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	96	chr13	20242494	chr13:20242494	C	CACGTACTATTTTTTTTTCTTAGACTTTCAAGAGTAGCAGAAGAGACAATAAAGGATT	127	PASS	AN=2;DP=96	GT	0/1
chr13	50570604	50570604	-	A	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	128	chr13	50570604	chr13:50570604	C	CA	91	PASS	AN=2;DP=128	GT	0/1
chr13	98018868	98018868	A	-	intronic	MBNL2	.	.	.	0.900896117	0.09892387	0.000180013	.	0.05644	0.07965	-0.293801652	32.93819297	21.49435	0.72448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	179	chr13	98018867	chr13:98018867	TA	T	75	PASS	AN=2;DP=179	GT	0/1
chr13	100635045	100635045	T	-	exonic	ZIC2	.	frameshift deletion	ZIC2:NM_007129:exon1:c.727delT:p.F244Sfs*12	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	467	chr13	100635044	chr13:100635044	CT	C	74	PASS	AN=2;DP=467	GT	0/1
chr14	45716018	45716018	-	T	exonic	MIS18BP1	.	frameshift insertion	MIS18BP1:NM_018353:exon2:c.471dupA:p.L158Ifs*7	2.30E-05	0.999045195	0.000931804	.	0.25957	0.06969	1.743518989	96.6383581	1469.92348	7.14407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	115	chr14	45716018	chr14:45716018	A	AT	91	PASS	AN=2;DP=115	GT	0/1
chr14	70714144	70714144	A	G	ncRNA_exonic	ADAM21P1	.	.	.	.	.	.	.	.	0.09205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	79	chr14	70714144	chr14:70714144	A	G	78	PASS	AN=2;DP=79	GT	0/1
chr14	72941317	72941317	-	T	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	176	chr14	72941317	chr14:72941317	G	GT	76	PASS	AN=2;DP=176	GT	0/1
chr14	80320318	80320318	-	T	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	288	chr14	80320317	chr14:80320317	AT	ATT,A	89	PASS	AN=2;DP=288	GT	0/1
chr14	80320318	80320318	T	-	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	288	chr14	80320317	chr14:80320317	AT	ATT,A	89	PASS	AN=2;DP=288	GT	0/1
chr14	91467521	91467521	-	A	intronic	RPS6KA5	.	.	.	0.999801807	0.000198193	4.15E-11	.	0.66327	0.31031	-0.178111357	40.44585987	117.20806	2.35411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	214	chr14	91467521	chr14:91467521	G	GA	58	PASS	AN=2;DP=214	GT	0/1
chr14	99637948	99637948	T	-	UTR3	BCL11B	NM_022898:c.*2540delA;NM_138576:c.*2540delA;NM_001282238:c.*2540delA;NM_001282237:c.*2540delA	.	.	0.929785242	0.070140307	7.45E-05	.	0.70076	0.16232	.	.	29.1619	0.93217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	164	chr14	99637947	chr14:99637947	AT	A	64	PASS	AN=2;DP=164	GT	0/1
chr14	104515928	104515928	T	-	intronic	TDRD9	.	.	.	3.82E-07	0.999438651	0.000560967	.	0.12943	0.10013	-0.191064116	39.27813163	513.83114	4.63761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	404	chr14	104515927	chr14:104515927	CT	C	83	PASS	AN=2;DP=404	GT	0/1
chr14	105242966	105242966	T	C	intronic	AKT1	.	.	.	0.980206587	0.019792772	6.41E-07	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:17611497}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer.; DISEASE: Proteus syndrome (PROTEUSS) [MIM:176920]: A highly variable, severe disorder of asymmetric and disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations. Many features of Proteus syndrome overlap with other overgrowth syndromes. {ECO:0000269|PubMed:21793738}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cowden syndrome 6 (CWS6) [MIM:615109]: A form of Cowden syndrome, a hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99568	0.9996	-1.001120478	8.321538099	12.57291	0.45861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	159	chr14	105242966	chr14:105242966	T	C	90	PASS	AN=2;DP=159	GT	0/1
chr15	20450149	20450149	T	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=37848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	1104	chr15	20450149	chr15:20450149	T	C	86	PASS	AN=2;DP=1104	GT	0/1
chr15	23108906	23108906	T	C	ncRNA_intronic	LOC283683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	275	chr15	23108906	chr15:23108906	T	C	82	PASS	AN=2;DP=275	GT	0/1
chr15	40951700	40951700	T	-	intronic	KNL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	199	chr15	40951699	chr15:40951699	CT	C	68	PASS	AN=2;DP=199	GT	0/1
chr15	41862354	41862436	GGTAAGGGGATGGGGATGTGGAGGGAGAGGCAGGTAATGATGAAAGACCTTGGAGCTGACCCCAAATCCTGGGTTTTCCTTTA	-	exonic	TYRO3	.	frameshift deletion	TYRO3:NM_001330264:exon10:c.1247delG:p.Q417Kfs*42,TYRO3:NM_006293:exon10:c.1382delG:p.Q462Kfs*42	0.761822543	0.238176797	6.60E-07	.	0.26568	0.24002	-0.817464788	11.97806086	1530.51507	7.27014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	368	chr15	41862353	chr15:41862353	GGGTAAGGGGATGGGGATGTGGAGGGAGAGGCAGGTAATGATGAAAGACCTTGGAGCTGACCCCAAATCCTGGGTTTTCCTTTA	G	68	PASS	AN=2;DP=368	GT	0/1
chr15	42144979	42144979	C	-	intronic	SPTBN5	.	.	.	1.09E-70	6.32E-11	1	.	0.16852	0.12091	.	.	13728.76893	25.43136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	221	chr15	42144978	chr15:42144978	GC	G	78	PASS	AN=2;DP=221	GT	0/1
chr15	55880103	55880103	C	-	UTR5	PYGO1	NM_001330326:c.-22delG	.	.	0.956651522	0.043239764	0.000108714	.	0.08925	0.11665	0.196671391	67.19155461	345.47846	3.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	738	chr15	55880102	chr15:55880102	TC	T	89	PASS	AN=2;DP=738	GT	0/1
chr15	59912374	59912374	-	T	downstream	GCNT3	dist=164	.	.	4.04E-09	0.054399435	0.945600561	.	0.11221	0.09788	0.446457185	77.97829677	58.26865	1.54572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	160	chr15	59912374	chr15:59912374	A	AT	70	PASS	AN=2;DP=160	GT	0/1
chr15	63127921	63127921	G	A	intronic	TLN2	.	.	.	0.999853231	0.000146769	3.85E-21	.	0.30553	0.44698	-3.469503166	0.353857042	2221.48407	8.67915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	188	chr15	63127921	chr15:63127921	G	A	.	PASS	AN=0;DP=188	GT	0/1
chr15	78397503	78397503	-	T	UTR3	CIB2	NM_001301224:c.*149_*150insA;NM_001271889:c.*149_*150insA;NM_001271888:c.*149_*150insA;NM_006383:c.*149_*150insA	.	.	0.000468493	0.667683033	0.331848474	DISEASE: Usher syndrome 1J (USH1J) [MIM:614869]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:23023331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40943	0.13588	-0.293801652	32.93819297	57.97419	1.53939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	178	chr15	78397503	chr15:78397503	G	GT	108	PASS	AN=2;DP=178	GT	0/1
chr15	99504134	99504134	-	C	UTR3	IGF1R	NM_001291858:c.*3463_*3464insC;NM_000875:c.*3463_*3464insC	.	.	0.55297426	0.4470257	4.02E-08	DISEASE: Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]: A disorder characterized by intrauterine growth retardation, poor postnatal growth and increased plasma IGF1 levels. {ECO:0000269|PubMed:14657428, ECO:0000269|PubMed:15928254}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99531	0.86203	-1.71613166	2.494692144	156.15124	2.73123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	570	chr15	99504134	chr15:99504134	G	GC	100	PASS	AN=2;DP=570	GT	0/1
chr16	1379810	1379810	-	A	intergenic	UBE2I;BAIAP3	dist=2791;dist=3796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	208	chr16	1379810	chr16:1379810	G	GA	94	PASS	AN=2;DP=208	GT	0/1
chr16	1382899	1382899	A	-	upstream	BAIAP3	dist=707	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	349	chr16	1382898	chr16:1382898	GA	G,GAA	45	PASS	AN=2;DP=349	GT	0/1
chr16	1382899	1382899	-	A	upstream	BAIAP3	dist=707	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	349	chr16	1382898	chr16:1382898	GA	G,GAA	45	PASS	AN=2;DP=349	GT	0/1
chr16	14863935	14863935	G	-	intergenic	NPIPA3;ABCC6P2	dist=4620;dist=52354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	1630	chr16	14863934	chr16:14863934	TG	T	93	PASS	AN=2;DP=1630	GT	0/1
chr16	15474951	15474951	C	T	intergenic	NPIPA5;MPV17L	dist=2800;dist=14660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	215	chr16	15474951	chr16:15474951	C	T	88	PASS	AN=2;DP=215	GT	0/1
chr16	21823156	21823156	A	G	ncRNA_exonic	RRN3P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	35	chr16	21823156	chr16:21823156	A	G	80	PASS	AN=2;DP=35	GT	0/1
chr16	29825016	29825016	C	-	exonic	PRRT2	.	frameshift deletion	PRRT2:NM_001256442:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_001256443:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_145239:exon2:c.641delC:p.R217Efs*11	0.301735693	0.679146035	0.019118272	DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761}. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease- causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.; DISEASE: Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30697	0.08082	0.549415813	81.38122199	216.41438	3.17873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	149	chr16	29825015	chr16:29825015	GC	G	97	PASS	AN=2;DP=149	GT	0/1
chr16	67300017	67300019	GAG	-	exonic	SLC9A5	.	nonframeshift deletion	SLC9A5:NM_001323972:exon14:c.1804_1806del:p.E607del,SLC9A5:NM_001323973:exon15:c.2104_2106del:p.E707del,SLC9A5:NM_001323974:exon15:c.1219_1221del:p.E412del,SLC9A5:NM_001323975:exon15:c.1222_1224del:p.E413del,SLC9A5:NM_004594:exon15:c.2107_2109del:p.E708del	0.036251926	0.963735021	1.31E-05	.	0.32414	0.12612	-0.865195027	10.79853739	86.06036	1.98043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	49	chr16	67300016	chr16:67300016	TGAG	T	59	PASS	AN=2;DP=49	GT	0/1
chr16	75327731	75327731	-	A	UTR3	CFDP1	NM_006324:c.*118_*119insT	.	.	0.084939582	0.90532901	0.009731408	.	0.69235	0.12239	-0.115612493	45.12856806	45.52056	1.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	24	chr16	75327731	chr16:75327731	G	GA	43	PASS	AN=2;DP=24	GT	0/1
chr17	3976075	3976075	C	G	intronic	ZZEF1	.	.	.	0.999923091	7.69E-05	6.61E-24	.	0.3881	0.10288	-3.376061946	0.389242746	5318.26057	15.07421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	chr17	3976075	chr17:3976075	C	G	58	PASS	AN=2;DP=21	GT	0/1
chr17	8093806	8093806	C	-	upstream	BORCS6	dist=242	.	.	.	.	.	.	0.38193	0.10905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	215	chr17	8093805	chr17:8093805	AC	A	65	PASS	AN=2;DP=215	GT	0/1
chr17	36357125	36357144	AAATATATTTGAGCACTTAA	-	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	200	chr17	36357124	chr17:36357124	TAAATATATTTGAGCACTTAA	T	68	PASS	AN=2;DP=200	GT	0/1
chr17	39974642	39974642	A	G	exonic	FKBP10	.	nonsynonymous SNV	FKBP10:NM_021939:exon4:c.A590G:p.K197R	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	1.0	0.010	T	0.0	0.026	B	0.003	0.080	B	0.041	0.240	N	1	0.090	P	-1.85	0.003	N	0.82	0.481	T	1.41	0.008	N	0.036	0.016	-0.983	0.343	T	0.001	0.003	T	.	.	.	-2.128	0.006	0.001	0.143	0.003	0.204	0.208	N	c	-1.729	-1.528	0.971	0.292	0.722	0.854	0	1.37	0.211	3.252	0.509	-0.229	0.095	0.999	0.424	0.808	0.339	11.540	0.497	FKBP-type peptidyl-prolyl cis-trans isomerase domain	ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000259623.1|ENSG00000141698.12	Adipose_Subcutaneous|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Thyroid|Whole_Blood	0.5	160	102	chr17	39974642	chr17:39974642	A	G	160	PASS	AN=2;DP=102	GT	0/1
chr17	40370236	40370236	G	-	exonic	STAT5B	.	frameshift deletion	STAT5B:NM_012448:exon9:c.1102delC:p.Q368Rfs*1	0.99995316	4.68E-05	1.24E-12	DISEASE: Growth hormone insensitivity with immunodeficiency (GHII) [MIM:245590]: A disease characterized by short stature, growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, resistance to hexogeneous growth hormone therapy, and recurrent infections. {ECO:0000269|PubMed:13679528, ECO:0000269|PubMed:15827093, ECO:0000269|PubMed:22419735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50895	.	-0.890882376	10.30313753	46.4952	1.31577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	441	chr17	40370235	chr17:40370235	TG	T	79	PASS	AN=2;DP=441	GT	0/1
chr17	42283996	42283996	A	-	UTR3	UBTF	NM_001076684:c.*614delT;NM_001076683:c.*614delT;NM_014233:c.*614delT	.	.	0.999998048	1.95E-06	2.65E-15	.	0.8196	0.17238	-1.155457828	6.168907761	10.71614	0.38835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	525	chr17	42283995	chr17:42283995	TA	T	71	PASS	AN=2;DP=525	GT	0/1
chr17	45664574	45664574	-	T	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.23	131	chr17	45664573	chr17:45664573	CT	CTT,C	25.23	PASS	AN=0;DP=131	GT	0/1
chr17	45664574	45664574	T	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.23	131	chr17	45664573	chr17:45664573	CT	CTT,C	25.23	PASS	AN=0;DP=131	GT	0/1
chr17	46621803	46621803	T	-	ncRNA_intronic	HOXB-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	937	chr17	46621802	chr17:46621802	AT	A	87	PASS	AN=2;DP=937	GT	0/1
chr17	48653397	48653397	C	-	exonic	CACNA1G	.	frameshift deletion	CACNA1G:NM_001256324:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256325:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256326:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256327:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256328:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256329:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256330:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256331:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256332:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256333:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256334:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256359:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256360:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256361:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_018896:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198376:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198377:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198378:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198379:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198380:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198382:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198383:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198384:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198385:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198386:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198387:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198388:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198396:exon8:c.1634delC:p.P547Lfs*16	0.999996517	3.48E-06	7.46E-19	.	0.50605	0.17372	-2.374358198	1.114649682	288.88842	3.63697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	805	chr17	48653396	chr17:48653396	GC	G	83	PASS	AN=2;DP=805	GT	0/1
chr17	59857599	59857599	-	A	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	52	chr17	59857599	chr17:59857599	C	CA	75	PASS	AN=2;DP=52	GT	0/1
chr17	59974794	59974794	-	T	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.11	93	chr17	59974794	chr17:59974794	C	CT	12.11	PASS	AN=0;DP=93	GT	0/1
chr17	61585272	61585272	G	-	intergenic	ACE;KCNH6	dist=9531;dist=15423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	563	chr17	61585271	chr17:61585271	TG	T	83	PASS	AN=2;DP=563	GT	0/1
chr17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	235	chr17	62852056	chr17:62852056	A	G	.	PASS	AN=0;DP=235	GT	0/1
chr17	74017554	74017554	G	T	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon9:c.C1006A:p.R336S,EVPL:NM_001988:exon9:c.C1006A:p.R336S	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.065	0.363	T	0.023	0.176	B	0.013	0.154	B	0.105	0.197	N	0.413	0.324	P	2.135	0.597	M	1.56	0.296	T	-2.91	0.609	D	0.291	0.350	-1.003	0.291	T	0.070	0.287	T	.	.	.	3.548	0.484	23.1	0.989	0.477	0.459	0.274	N	c	-0.189	-0.094	0.027	0.138	0.487	0.133	0	3.51	0.391	1.922	0.394	0.136	0.221	0.982	0.353	0.875	0.366	6.907	0.233	.	.	.	0.5	92	143	chr17	74017554	chr17:74017554	G	T	92	PASS	AN=2;DP=143	GT	0/1
chr17	76001227	76001227	T	-	intronic	TNRC6C	.	.	.	0.999997824	2.18E-06	7.00E-16	.	0.32049	0.10248	-1.537897124	3.338051427	1348.87379	6.89482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	279	chr17	76001226	chr17:76001226	CT	C	90	PASS	AN=2;DP=279	GT	0/1
chr17	79507107	79507108	CG	-	UTR3	FAAP100	NM_025161:c.*738_*737delCG	.	.	.	.	.	.	0.14739	0.16001	0.363735434	74.71101675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	565	chr17	79507106	chr17:79507106	CCG	C	79	PASS	AN=2;DP=565	GT	0/1
chr18	13099601	13099601	-	T	intronic	CEP192	.	.	.	7.44E-10	0.999999897	1.02E-07	.	0.09044	0.10852	1.493675397	95.37037037	4911.21175	14.29193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	50	chr18	13099601	chr18:13099601	G	GT	75	PASS	AN=2;DP=50	GT	0/1
chr18	57013193	57013193	-	T	exonic	LMAN1	.	frameshift insertion	LMAN1:NM_005570:exon8:c.912dupA:p.E305Rfs*19	0.486069839	0.513889663	4.05E-05	DISEASE: Factor V and factor VIII combined deficiency 1 (F5F8D1) [MIM:227300]: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:10090935, ECO:0000269|PubMed:19787799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1019	0.17526	-0.045835247	50.34206181	760.68404	5.46719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	320	chr18	57013193	chr18:57013193	C	CT	67	PASS	AN=2;DP=320	GT	0/1
chr19	757412	757412	A	G	exonic	MISP	.	nonsynonymous SNV	MISP:NM_173481:exon2:c.A466G:p.S156G	1.95E-10	0.034098173	0.965901827	.	0.13168	.	-0.031281682	50.5779665	693.62656	5.25135	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.904	0.086	N	1	0.090	P	-0.82	0.015	N	0.75	0.502	T	0.42	0.034	N	0.015	0.002	-0.951	0.408	T	0.000	0.000	T	.	.	.	-1.729	0.012	0.002	0.144	0.003	0.019	0.058	N	c	-1.589	-1.521	0.002	0.092	0.581	0.326	0	-0.862	0.101	-1.156	0.032	-0.535	0.048	0.000	0.063	0.675	0.304	5.825	0.177	.	.	.	0.5	111	72	chr19	757412	chr19:757412	A	G	111	PASS	AN=2;DP=72	GT	0/1
chr19	1371193	1371193	C	A	intronic	MUM1	.	.	.	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	261	chr19	1371193	chr19:1371193	C	A	62	PASS	AN=2;DP=261	GT	0/1
chr19	4294807	4294807	G	A	exonic	TMIGD2	.	nonsynonymous SNV	TMIGD2:NM_001308232:exon2:c.C53T:p.P18L,TMIGD2:NM_001169126:exon3:c.C413T:p.P138L,TMIGD2:NM_144615:exon3:c.C413T:p.P138L	0.01525187	0.878338597	0.106409533	.	0.08093	.	1.931026376	97.46992215	710.71198	5.29848	0.118	0.281	T	0.032	0.189	B	0.015	0.162	B	.	.	.	1	0.090	P	0.345	0.112	N	1.62	0.317	T	-2.87	0.603	D	0.021	0.005	-0.996	0.309	T	0.000	0.000	T	.	.	.	-0.525	0.054	0.191	0.781	0.117	0.008	0.032	N	c	-1.298	-1.427	0.000	0.042	0.516	0.203	0	-4.98	0.028	-0.450	0.068	-0.094	0.117	0.000	0.063	0.022	0.137	0.988	0.013	.	.	.	0.5	54	35	chr19	4294807	chr19:4294807	G	A	54	PASS	AN=2;DP=35	GT	0/1
chr19	6414075	6414075	-	A	UTR3	KHSRP	NM_003685:c.*47_*48insT	.	.	0.999711222	0.000288778	5.13E-10	.	0.45176	0.15486	-0.690637458	15.12149092	19.12445	0.65912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	176	chr19	6414075	chr19:6414075	G	GA	50	PASS	AN=2;DP=176	GT	0/1
chr19	13318896	13318896	A	-	intronic	CACNA1A	.	.	.	1	2.24E-10	1.12E-27	DISEASE: Spinocerebellar ataxia 6 (SCA6) [MIM:183086]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder. {ECO:0000269|PubMed:16325861, ECO:0000269|PubMed:20682717, ECO:0000269|PubMed:8988170, ECO:0000269|PubMed:9345107}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]: A subtype of migraine with aura associated with ictal hemiparesis and, in some families, cerebellar ataxia and atrophy. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. Migraine with aura is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking. {ECO:0000269|PubMed:10408532, ECO:0000269|PubMed:11409427, ECO:0000269|PubMed:11439943, ECO:0000269|PubMed:15032980, ECO:0000269|PubMed:18400034, ECO:0000269|PubMed:8898206}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Episodic ataxia 2 (EA2) [MIM:108500]: An autosomal dominant disorder characterized by acetozolamide-responsive attacks of ataxia, migraine-like symptoms, interictal nystagmus, and cerebellar atrophy. {ECO:0000269|PubMed:10987655, ECO:0000269|PubMed:11176968, ECO:0000269|PubMed:11723274, ECO:0000269|PubMed:12420090, ECO:0000269|PubMed:14718690, ECO:0000269|PubMed:15173248, ECO:0000269|PubMed:15293273, ECO:0000269|PubMed:18602318, ECO:0000269|PubMed:19232643, ECO:0000269|PubMed:20129625, ECO:0000269|PubMed:21696515, ECO:0000269|PubMed:8898206, ECO:0000269|PubMed:9302278}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.58636	0.55905	-1.782298694	2.270582685	4523.77922	13.50808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	454	chr19	13318895	chr19:13318895	CA	C	76	PASS	AN=2;DP=454	GT	0/1
chr19	33490500	33490500	C	T	exonic	RHPN2	.	nonsynonymous SNV	RHPN2:NM_033103:exon10:c.G1217A:p.R406Q	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	0.33	0.131	T	0.046	0.205	B	0.011	0.145	B	0.546	0.053	N	1	0.090	N	0.72	0.188	N	1.92	0.231	T	-1.58	0.381	N	0.045	0.025	-1.048	0.150	T	0.066	0.274	T	0.014	0.345	T	2.284	0.336	18.06	0.984	0.411	0.008	0.031	N	c	-1.114	-1.210	1.000	0.425	0.672	0.522	0	-6.97	0.015	-0.603	0.057	-0.079	0.119	0.000	0.063	0.088	0.184	3.396	0.068	BRO1 domain	.	.	0.5	109	148	chr19	33490500	chr19:33490500	C	T	109	PASS	AN=2;DP=148	GT	0/1
chr19	44098881	44098881	G	-	intronic	IRGQ	.	.	.	0.001197228	0.956861915	0.041940857	.	0.11132	0.10002	0.174625237	65.9648502	46.00143	1.30616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	337	chr19	44098880	chr19:44098880	AG	A	155	PASS	AN=2;DP=337	GT	0/1
chr19	49982165	49982165	-	C	splicing	FLT3LG	NM_001278638:exon6:c.97-1->C;NM_001204502:exon6:c.343-1->C;NM_001459:exon6:c.343-1->C;NM_001278637:exon6:c.97-1->C;NM_001204503:exon5:c.343-1->C	.	.	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	289	chr19	49982165	chr19:49982165	G	GC	89	PASS	AN=2;DP=289	GT	0/1
chr19	55106288	55106288	A	C	exonic	LILRA1	.	nonsynonymous SNV	LILRA1:NM_001278319:exon3:c.A229C:p.I77L,LILRA1:NM_001278318:exon4:c.A229C:p.I77L,LILRA1:NM_006863:exon4:c.A229C:p.I77L	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	0.384	0.165	T	0.0	0.026	B	0.0	0.063	B	0.222	0.035	N	1	0.090	N	-2.02	0.002	N	5.83	0.007	T	0.68	0.022	N	0.035	0.202	-0.917	0.459	T	0.001	0.003	T	.	.	.	-1.537	0.016	0.002	0.802	0.126	0.000	0.002	N	c	-1.960	-1.968	1.000	0.517	0.610	0.352	0	-1.94	0.071	-3.526	0.005	-1.428	0.011	0.000	0.063	0.000	0.016	4.396	0.107	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	90	273	chr19	55106288	chr19:55106288	A	C	90	PASS	AN=2;DP=273	GT	0/1
chr19	58084294	58084294	G	A	exonic	ZNF416	.	synonymous SNV	ZNF416:NM_017879:exon4:c.C978T:p.Y326Y	0.000574204	0.896616643	0.102809153	.	0.0469	.	-0.666770504	15.86459071	44.10909	1.26615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	189	chr19	58084294	chr19:58084294	G	A	41	PASS	AN=2;DP=189	GT	0/1
chr20	3026937	3026937	G	-	intronic	MRPS26	.	.	.	0.187857588	0.762148525	0.049993888	.	0.10007	0.08706	.	.	10.24285	0.37333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	452	chr20	3026936	chr20:3026936	CG	C	69	PASS	AN=2;DP=452	GT	0/1
chr20	21493013	21493013	C	-	exonic	NKX2-2	.	frameshift deletion	NKX2-2:NM_002509:exon2:c.370delG:p.D124Tfs*59	0.337334272	0.648129386	0.014536342	.	0.48097	0.24974	0.505321956	80.00707714	296.89141	3.67718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	933	chr20	21493012	chr20:21493012	TC	T	79	PASS	AN=2;DP=933	GT	0/1
chr20	32664877	32664877	C	T	exonic	RALY	.	synonymous SNV	RALY:NM_007367:exon7:c.C654T:p.G218G,RALY:NM_016732:exon8:c.C702T:p.G234G	0.55457384	0.442614262	0.002811898	.	0.18001	0.13451	-0.093566408	46.7386176	666.56385	5.16662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	328	chr20	32664877	chr20:32664877	C	T	60	PASS	AN=2;DP=328	GT	0/1
chr20	33232046	33232046	G	T	intronic	PIGU	.	.	.	0.813069113	0.186732529	0.000198358	.	0.17799	0.11142	-0.402212257	26.7338995	75.12131	1.81375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	72	chr20	33232046	chr20:33232046	G	T	83	PASS	AN=2;DP=72	GT	0/1
chr20	48439582	48439582	-	T	intronic	SLC9A8	.	.	.	2.82E-05	0.983591566	0.016380268	.	0.06517	0.15107	-0.666770504	15.86459071	202.63697	3.07202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	35	chr20	48439582	chr20:48439582	A	AT	71	PASS	AN=2;DP=35	GT	0/1
chr20	51588866	51588868	GAG	-	upstream	TSHZ2	dist=78	.	.	0.406843773	0.5927903	0.000365927	.	0.13647	0.11806	-0.916836882	9.831328143	361.35552	4.02303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	203	chr20	51588865	chr20:51588865	AGAG	A	119	PASS	AN=2;DP=203	GT	0/1
chr21	10942644	10942644	A	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	382	chr21	10942643	chr21:10942643	CA	C	83	PASS	AN=2;DP=382	GT	0/1
chr21	11058061	11058061	T	C	UTR3	BAGE	NM_001187:c.*367A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	253	chr21	11058061	chr21:11058061	T	C	104	PASS	AN=2;DP=253	GT	0/1
chr21	35446629	35446629	-	A	intronic	MRPS6;SLC5A3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	310	chr21	35446629	chr21:35446629	T	TA	77	PASS	AN=2;DP=310	GT	0/1
chr21	38132055	38132055	T	C	exonic	HLCS	.	nonsynonymous SNV	HLCS:NM_000411:exon10:c.A1768G:p.M590V,HLCS:NM_001242784:exon10:c.A1768G:p.M590V,HLCS:NM_001242785:exon10:c.A1768G:p.M590V	0.486548324	0.513252415	0.000199261	.	0.07149	0.25106	-0.591542347	18.24722812	151.46286	2.69061	0.348	0.124	T	0.002	0.090	B	0.007	0.121	B	0.112	0.194	N	1.000	0.192	N	0.735	0.189	N	-3.32	0.939	D	-1.09	0.283	N	0.178	0.218	-0.471	0.697	T	0.400	0.751	T	0.042	0.603	D	0.448	0.137	7.021	0.640	0.072	0.097	0.152	N	c	-1.260	-1.285	1.000	0.747	0.638	0.428	0	-8.42	0.008	0.029	0.134	0.008	0.138	0.007	0.175	0.987	0.523	2.446	0.042	Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain	.	.	0.5	.	50	chr21	38132055	chr21:38132055	T	C	.	PASS	AN=0;DP=50	GT	0/1
chr22	19396044	19396044	T	C	exonic	HIRA	.	nonsynonymous SNV	HIRA:NM_003325:exon3:c.A173G:p.N58S	0.999998171	1.83E-06	4.58E-16	.	0.94243	0.2323	-1.374132436	4.429110639	37.48735	1.116	0.28	0.193	T	0.154	0.265	B	0.085	0.279	B	0.000	0.843	D	1	0.810	D	0.16	0.090	N	-0.35	0.686	T	-2.33	0.516	N	0.069	0.103	-0.929	0.442	T	0.145	0.469	T	0.013	0.319	T	1.210	0.211	11.80	0.972	0.323	0.894	0.495	D	c	-0.208	0.028	1.0	0.983	0.707	0.730	0	5.5	0.813	2.917	0.483	1.061	0.807	1.000	0.715	1.000	0.888	15.776	0.779	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	.	.	0.5	94	181	chr22	19396044	chr22:19396044	T	C	94	PASS	AN=2;DP=181	GT	0/1
chr22	23959752	23959752	G	A	intronic	DRICH1	.	.	.	.	.	.	.	.	.	1.282454727	93.71313989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	168	chr22	23959752	chr22:23959752	G	A	84	PASS	AN=2;DP=168	GT	0/1
chr22	32650200	32650200	C	T	exonic	SLC5A4	.	nonsynonymous SNV	SLC5A4:NM_014227:exon2:c.G136A:p.A46T	2.60E-13	0.125757351	0.874242649	.	0.08441	0.1124	0.736704836	86.32932295	914.47301	5.88119	0.017	0.512	D	0.228	0.288	B	0.206	0.354	B	0.000	0.843	D	0.000	0.588	P	2.89	0.840	M	-2.33	0.879	D	-1.68	0.401	N	0.167	0.207	-0.909	0.470	T	0.003	0.009	T	.	.	.	4.996	0.672	25.1	0.995	0.702	0.940	0.597	D	c	-0.113	-0.109	0.000	0.064	0.554	0.246	0	3.19	0.356	0.590	0.235	0.038	0.153	0.998	0.411	0.133	0.200	12.082	0.528	.	.	.	0.5	95	45	chr22	32650200	chr22:32650200	C	T	95	PASS	AN=2;DP=45	GT	0/1
chr22	32756652	32756652	A	G	exonic	RFPL3	.	nonsynonymous SNV	RFPL3:NM_001098535:exon2:c.A787G:p.S263G,RFPL3:NM_006604:exon3:c.A700G:p.S234G	0.000158443	0.437571789	0.562269768	.	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	0.219	0.190	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.935	0.237	L	0.12	0.611	T	-0.28	0.116	N	0.056	0.078	-1.028	0.211	T	0.108	0.392	T	.	.	.	-1.537	0.016	0.002	0.517	0.045	0.000	0.002	N	c	-1.461	-1.545	0.003	0.100	0.549	0.223	0	0.115	0.139	-0.551	0.061	-1.073	0.019	0.000	0.063	0.004	0.083	6.122	0.193	B30.2/SPRY domain|Concanavalin A-like lectin/glucanase domain|SPRY domain	.	.	0.5	125	410	chr22	32756652	chr22:32756652	A	G	125	PASS	AN=2;DP=410	GT	0/1
chr22	37768971	37768971	C	T	UTR3	ELFN2	NM_052906:c.*141G>A	.	.	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	743	chr22	37768971	chr22:37768971	C	T	91	PASS	AN=2;DP=743	GT	0/1
chr22	38254768	38254768	-	T	intronic	EIF3L	.	.	.	0.938813614	0.061184231	2.16E-06	.	0.10378	0.12326	-0.758599262	13.32861524	8.36913	0.30609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	113	chr22	38254768	chr22:38254768	G	GT	62	PASS	AN=2;DP=113	GT	0/1
chrX	57620213	57620213	C	G	exonic	ZXDB	.	nonsynonymous SNV	ZXDB:NM_007157:exon1:c.C1732G:p.L578V	0.842955569	0.154160523	0.002883908	.	0.06264	0.09943	.	.	96.86419	2.12723	0.126	0.272	T	0.997	0.689	D	0.978	0.725	D	0.000	0.481	D	0.950	0.377	D	2.73	0.801	M	3.01	0.091	T	-1.43	0.352	N	0.35	0.411	-1.122	0.022	T	0.048	0.205	T	0.020	0.426	T	0.986	0.188	10.58	0.978	0.353	0.940	0.595	D	.	.	.	1.000	0.747	.	.	.	2.96	0.332	3.684	0.542	0.887	0.390	1.000	0.715	0.997	0.653	8.628	0.329	.	.	.	0.5	.	57	chrX	57620213	chrX:57620213	C	G	.	PASS	AN=0;DP=57	GT	0/1
chrX	70979225	70979246	CGCGTGCACATGTGCGCGCGCG	-	intergenic	BCYRN1;CXorf49	dist=30263;dist=3894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	139	chrX	70979224	chrX:70979224	ACGCGTGCACATGTGCGCGCGCG	A	61	PASS	AN=2;DP=139	GT	0/1
chrX	76918818	76918818	A	G	intronic	ATRX	.	.	.	0.999999982	1.77E-08	2.33E-22	DISEASE: Alpha-thalassemia mental retardation syndrome, X-linked (ATRX) [MIM:301040]: A disorder characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions. {ECO:0000269|PubMed:10204841, ECO:0000269|PubMed:10417298, ECO:0000269|PubMed:10660327, ECO:0000269|PubMed:10995512, ECO:0000269|PubMed:12116232, ECO:0000269|PubMed:16955409, ECO:0000269|PubMed:7697714, ECO:0000269|PubMed:8968741, ECO:0000269|PubMed:9043863, ECO:0000269|PubMed:9326931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, syndromic, with hypotonic facies 1 (MRXSHF1) [MIM:309580]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSHF1 is a syndromic mental retardation. Clinical features include severe mental retardation, dysmorphic facies, and a highly skewed X-inactivation pattern in carrier women. Other more variable features include hypogonadism, deafness, renal anomalies, and mild skeletal defects. {ECO:0000269|PubMed:10398237, ECO:0000269|PubMed:10751095, ECO:0000269|PubMed:11050622, ECO:0000269|PubMed:15565397, ECO:0000269|PubMed:16222662, ECO:0000269|PubMed:8630485}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alpha-thalassemia myelodysplasia syndrome (ATMDS) [MIM:300448]: A disorder characterized by hypochromic, microcytic red blood cells, hemoglobin H detected in peripheral blood, and multilineage myelodysplasia. {ECO:0000269|PubMed:12858175}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.56316	-0.925889687	9.754659118	107.54684	2.25148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	112	chrX	76918818	chrX:76918818	A	G	60	PASS	AN=2;DP=112	GT	0/1
chrX	108780404	108780404	C	G	UTR5	NXT2	NM_001242618:c.-939C>G	.	.	0.777280518	0.215400937	0.007318545	.	0.0023	0.02889	0.013025609	54.62962963	1.49817	0.05093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	276	chrX	108780404	chrX:108780404	C	G	85	PASS	AN=2;DP=276	GT	0/1
chrX	153290176	153290176	-	T	UTR3	MECP2	NM_004992:c.*5641_*5642insA	.	.	0.698089048	0.298098137	0.003812815	DISEASE: Angelman syndrome (AS) [MIM:105830]: A neurodevelopmental disorder characterized by severe motor and intellectual retardation, ataxia, frequent jerky limb movements and flapping of the arms and hands, hypotonia, seizures, absence of speech, frequent smiling and episodes of paroxysmal laughter, open-mouthed expression revealing the tongue. {ECO:0000269|PubMed:11283202}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, syndromic, 13 (MRXS13) [MIM:300055]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS13 patients manifest mental retardation associated with other variable features such as spasticity, episodes of manic depressive psychosis, increased tone and macroorchidism. {ECO:0000269|PubMed:10986043, ECO:0000269|PubMed:11007980, ECO:0000269|PubMed:11309367, ECO:0000269|PubMed:11805248, ECO:0000269|PubMed:11885030, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12325019, ECO:0000269|PubMed:12615169, ECO:0000269|PubMed:16966553}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Rett syndrome (RTT) [MIM:312750]: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. {ECO:0000269|PubMed:10508514, ECO:0000269|PubMed:10577905, ECO:0000269|PubMed:10745042, ECO:0000269|PubMed:10767337, ECO:0000269|PubMed:10814719, ECO:0000269|PubMed:10944854, ECO:0000269|PubMed:10991688, ECO:0000269|PubMed:10991689, ECO:0000269|PubMed:11055898, ECO:0000269|PubMed:11241840, ECO:0000269|PubMed:11269512, ECO:0000269|PubMed:11283202, ECO:0000269|PubMed:11376998, ECO:0000269|PubMed:11402105, ECO:0000269|PubMed:11706982, ECO:0000269|PubMed:11738883, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12567420, ECO:0000269|PubMed:12966522, ECO:0000269|PubMed:12966523, ECO:0000269|PubMed:15034579, ECO:0000269|PubMed:15057977}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Autism, X-linked 3 (AUTSX3) [MIM:300496]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:12770674}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Encephalopathy, neonatal severe, due to MECP2 mutations (ENS-MECP2) [MIM:300673]: A neurodevelopmental disorder characterized by severe neonatal encephalopathy, developmental delay, mental retardation, microcephaly, seizures. Additional features include respiratory insufficiency and central hypoventilation, gastroesophageal reflux, axial hypotonia, hyperreflexia and dyskinetic movements. {ECO:0000269|PubMed:11238684}. Note=The disease is caused by mutations affecting the gene represented in this entry. The MECP2 gene is mutated in Rett syndrome, a severe neurodevelopmental disorder that almost always occurs in females. Although it was first thought that MECP2 mutations causing Rett syndrome were lethal in males, later reports identified a severe neonatal encephalopathy in surviving male sibs of patients with Rett syndrome. Additional reports have confirmed a severe phenotype in males with Rett syndrome-associated MECP2 mutations.; DISEASE: Mental retardation, X-linked, syndromic, Lubs type (MRXSL) [MIM:300260]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSL patients manifest mental retardation associated with variable features. They include swallowing dysfunction and gastroesophageal reflux with secondary recurrent respiratory infections, hypotonia, mild myopathy and characteristic facies such as downslanting palpebral fissures, hypertelorism and a short nose with a low nasal bridge. {ECO:0000269|PubMed:16080119}. Note=The disease is caused by mutations affecting the gene represented in this entry. Increased dosage of MECP2 due to gene duplication appears to be responsible for the mental retardation phenotype.; 	0.43937	0.69428	-0.885424753	10.4623732	83.03146	1.93651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	181	chrX	153290176	chrX:153290176	G	GT	82	PASS	AN=2;DP=181	GT	0/1
